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A chymotrypsin inhibitor (MCCI) was isolated from the seeds of Momordica 
cochinchinensis, the Chinese drug 'Mubiezhi'which was mainly used for treating 
lymphadenitis, mastitis and hemorrdhoids. The purification procedure involved a 
combination of affinity chromatography on chymotrypsin-Sepharose 4B and reversed 
phase HPLC. Unlike trypsin and elastase inhibitors, chymotrypsin-specific inhibitors in 
Cucurbitaceous seeds have not been identified. From 138 grams of seeds, 1.44 mg of 
the inhibitors could be obtained. The inhibitor could inhibit chymotrypsin and subtilisin 
but had at least 50-fold lower inhibitory activity towards trypsin and elastase. MCCI 
was stable at temperature up to 100 °C and pH ranging from 2 to 12. More than 90% of 
its inhibitory activity could be retained after 20 min of incubation. A peptide fragment 
of MCCI, generated by digestion with the lysyl endopeptidase was successfully 
sequenced and twenty-three amino acid residues were identified. Sequence analysis 
revealed high homology with members of the potato I protease inhibitor family. 
ESI-mass spectrum showed that native MCCI had a molecular mass of 7,514 daltons. 
To our knowledge, MCCI is the first chymotrypsin-specific potato type I inhibitor 
purified from Cucurbitaceous plants. 
i 
Previous investigation on protease inhibitors were mainly confined to its 
physico-chemical properties, while the biological activity remains relatively 
unexplored. In this study, MCCI was studied with respect to its immunomodulatory, 
hepatoprotective effect and cytotoxicity on tumor cells. 
In the study of the effect on immune cells, MCCI (at 20 |ig/ml) was found to stimulate 
the proliferation of splenic lymphocytes by 8-9 fold. The growth stimulation effect on 
bone marrow cells was even stronger. The stimulation effects in both cases were 
comparable with those of the mitogen, Concanavalin A. The proliferation of 
lymphocytes was accompanied by an increase of 3.5-fold in the production of 
interleukin 2, a cytokine which is important for growth and differentiation of 
lymphocytes. From the experiments on the activation of oxidants involving LPS 
pre-incubation in neutrophils and ATP pre-incubation in macrophages, MCCI inhibited 
hydrogen peroxide formation by 80 % and reverted cell viability. 
Using primary rat hepatocytes as a model, MCCI enhanced the activities of some 
antioxidant enzymes, for example, glutathione-S-transferase by 55% and superoxide 
dismutase by 18% at 100 fig/ml. The same dosage of MCCI was also found to inhibit 
ii 
the rBHP-induced lipid peroxidation by 60 % and the potency was comparable to that 
of a known lipid peroxidation inhibitor BHT. MCCI could also increase the cellular 
ratio of reduced form of glutathione by 7 fold and decrease the cellular level of GSSG, 
thus counteracting the effect of ^BHP in hepatocytes. 
For the cytotoxicity on different tumor cells, MCCI inhibited the growth of HepG2 
(human liver cancer cell line) by 45 %, MCF-7 (human breast cancer cell line) by 25 % 
and HL 60 human (human leukemia) by 15 % with 200 |ag/ml MCCI administration 
and an incubation time of 48 hr. Though there was no evidence for the induction of 
apoptosis by MCCI, cell cycle arrest on GO/Gl phase could be observed in the cases of 
HepG2 and MCF-7. 
The balance between proteases and protease inhibitors is very important in normal 
homeqstatic processes. MCCI, a chymotrypsin-specific protease inhibitor purified from 
the seeds of Momordica cochinchinensis, may be of medicinal value, particularly in 
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Chapter 1 Purification and characterization of the 
chymotrypsin inhibitor (MCCI) from the 
seeds oi Momordica cochinchinensis 
1.1 Introduction 
Protease inhibitors are widely distributed in the animal, plant and 
microorganism kingdoms. In plant, protease inhibitors are believed to play 
an important role in the defense against attack by microorganism and insects 
by inhibiting the microbial proteases and the digestive enzymes of insect 
larvae. Moreover, these protease inhibitors serve as storage or reserve 
proteins and may also be involved in the control of endogenous proteases 
during seed dormancy (Shibata et al, 1986). 
Different types of protease inhibitors have been detected in plant, depending 
primarily on the mechanism of inhibition. Among them, serine protease 
inhibitors are most common and have been isolated from various sources, 
particularly the seeds, of plants from the families of Leguminosae, 
Graminaceae and Solanceae. 
1 
1.1.1 Classification of protease inhibitor 
Several different methods can be used to classify the serine protease 
inhibitors. The most common one is based on the molecular weight and the 
proportion of cysteine residues in the inhibitor. Three major types of serine 
protease inhibitors have thus been classified, namely, Kunitz type, 
Bowman-Birk type and squash type (Norioka and Ikenaka, 1983; Shibata 
et aL, 1986; Wieczorek et al., 1985). In addition, there are also some less 
common types of serine protease inhibitors, for example, potato type 
(Hejgaard et al, 1994; Antcheva et al., 1996) and Kazal type 
(Wilimowska-Pelc et al., 2002) 
The largest serine protease inhibitor, with a molecular weight around 20,000, 
belongs to the Kunitz type (Kimura et al, 1993). The type of inhibitors with 
a molecular weight around 10,000 is the Bowman-Birk type (Norioka and 
Ikenaka, 1983). The squash type inhibitor is the smallest one among the 
three and has a molecular weight around 3,500 (Lee and Lin, 1995). The 
molecular weight of potato type and Kazal type inhibitors are in the 
intermediate range from 6,000 to 20,000 (Antcheva et al, 1996; 
Wilimowska-Pelc et al., 2002). 
2 
Besides molecular weight, another determining factor in the classification of 
serine protease inhibitors is the content of half-cystine residues, i.e. the 
number of intra-molecular disulfide bonds in the inhibitor molecule 
(Hamato et al, 1995). Different types of serine protease inhibitors have 
different number of disulfide bonds. The Kunitz, Bowman-Birk, squash and 
Kazal types of serine protease inhibitors have two, seven, three and three 
disulfide bonds respectively (Argall et al, 1994; Hara et al., 1989; Kalume 
et al, 1995; Wilimowska-Pelc et al, 2002). On the contrary, potato I 
inhibitors usually contain no or at most one cysteine residue or disulfide 
bond in its structure. 
The number of active sites also varies among the different types of 
„ inhibitors. Usually, the Kunitz and the Bowman-Birk serine protease 
inhibitors have two independent active sites which can inhibit independently 
different serine protease. For example, one site inhibits the activity of 
trypsin while the other inhibits the activity of chymotrypsin. The squash 
type serine protease inhibitor is single-headed, i.e. it possesses only one 
active site. This can be easily understood since the squash type inhibitors are 
so small that they can only afford to block the active site of a single protease 
, 3 
molecule (de Freitas et cd., 1997). The active site of some potato inhibitors 
share similar active site conformation with soybean Kunitz inhibitor (Balls 
and Ryan, 1975) while the active site of the Kazal type inhibitors is less 
characterized. 
1.1.2 Therapeutic potential of protease inhibitors 
Proteases are involved in numerous biological processes, including food 
digestion, the cascade systems in blood clotting and complement, 
fertilization, fibrinolysis, activation of hormones, and degradation of 
endogenous proteins within the cell (Neurath, 1984). Proteases have also 
been implicated in various diseases including trauma, tumor metastasis, 
emphysema and arthritis (Bolewska et al., 1995). Thus, regulation of 
protease activity by specific inhibitors to prevent uncontrolled proteolysis is 
one of the most common mechanisms in physiological homeostasis. 
Epidemiological studies have identified specific protease inhibitors as 
possible protective agents in the decreased occurrence of breast, colon and 
prostate cancers in vegetarian populations (Kennedy, 1995). Synthetic and 
natural protease inhibitors have been shown to inhibit tumor promotion both 
. 4 
in in vitro and in vivo experimental systems (Kennedy, 1988). The 
anti-carcinogenic mechanism of ingested protease inhibitors may involve 
the indirect effect of partially blocking protein absorption (Hocman, 1992). 
Protease inhibitors may also control metastasis of cancer cells by inhibiting 
the proteases secreted by cancer cells (Tamir et al, 1996). As a result, 
protease inhibitors have the potential of being used as cancer 
chemopreventive agents in human (Kennedy, 1998). . 
Soybean concentrates, particularly the Bowman Birk inhibitor (BBI), have 
been shown to suppress carcinogenesis in different organ systems/tissue 
types (e.g. colon, liver, lung, esophagus, cheek pouch and cells of 
hematopoietic origin) as well as in different species (e.g. mice, rats and 
hamsters). This anti-carcinogenic effect was also observed when soybean 
concentrates were administered to animals through different routes 
(including through the diet). The soybean concentrate was found to be 
- effective for different types of cancer (e.g. squamous cell carcinomas, 
adenocarcinomas, angiosarcomas, etc) induced by a wide variety of 
chemical and physical carcinogens (e.g. ionizing radiation) (Kennedy, 1998). 
The BBI concentrate has proceeded to the clinical trial stage (Kennedy and 
. 5 
f 
Manzone, 1995). Attempts are being made recently to identify potential 
intracellular target enzymes and proteins for its anti-carcinogenic effect. 
Apart from acting as cancer chemopreventive agents, serine protease 
inhibitors are also good candidates as drugs for cardiovascular diseases, as 
they can inhibit some serine proteases in the blood coagulation system. 
Some serine protease inhibitors can prolong the clotting time of human 
plasma and inhibit the amidolytic activities of coagulation factors, which are 
implicated in cardiovascular diseases (Hayashi et ai, 1994). 
1.2 Rationale of the present study 
Knowing that serine protease inhibitors may have important applications in 
medicine, effort was put on discovering，purifying and characterizing more 
new serine protease inhibitors with different properties so as to expand the 
‘ list of choice to satisfy the need for different applications. 
Among the different types of serine protease inhibitors, trypsin inhibitors 
are the most common one. Many chymotrypsin and elastase protease 
6 
inhibitors have also been isolated from a wide variety of species. In 
Cucurbitaceae, serine protease inhibitors have been isolated from the seeds 
of Cucurbita, Cucumis and Momordica. For example, from Momordica 
charantia, at least ten different protease inhibitors, namely, MCI-I (Bowman 
Birk inhibitor), MCI-2 (Kunitz inhibitor), MCI-3 (potato I inhibitor), 
MCTI-I，MCTI-II, MCTI-III, MCEI-I，MCEI-II, MCEI-III and MCEI-IV 
(squash inhibitors) have been isolated (Zeng et al, 1989; Kamei et al., 
2000). A number of squash type trypsin inhibitors have also been isolated 
from Momordica cochinchinensis (Huang et al., 1999). Although some 
trypsin inhibitors are also known to interact with chymotrypsin (Troncoso et 
al., 2003; Argall et al., 1994), it is interesting to note that among the large 
number of serine protease inhibitors from Cucurbitaceae, none of them are 
chymotrypsin-specific. 
‘ Recently, a screening for chymotrypsin inhibitors in different members of 
‘ Cucurbitaceae was carried out (Wong, 2001). Among the eleven species 
examined, only Momordica cochinchinensis was found to possess 
I 
significant chymotrypsin-inhibitory activity. In that study, the inhibitor was 
purified by a combination of SP-Sepharose and reversed phase HPLC 
. 7 
chromatographies. While it was confirmed that the inhibitor was 
chymotrypsin-specific, the physical and kinetic properties of the inhibitor 
have not been examined in detail. 
The seed of Momordica cochinchinensis is commonly used in traditional 
Chinese medicine. It was found to be effective in the treatment of 
pyodermas, mastitis, tuberculous, cervical lymphadenitis, ringworm 
infections, freckles, sebaceous cysts, hemorrhoids and hemangiomas 
(Cheung and Li, 1985). The active components, including momordic acid, 
oleanolic acid, a-eleostearic acid, gypsogenin and mycose (Cheung and Li, 
1985) have been purified and well-investigated. The presence of a 
chymotrypsin-specific inhibitor may also contribute to the therapeutic effect 
of Momordica cochinchinensis. 
The objective of the present study was to isolate and characterize the 
, chymotrypsin inhibitor (MCCI) from Momordica cochinchinensis. A 
modified procedure, involving a combination of affinity chromatography on 
chymotrypsin-Sepharose 4B with reversed phase HPLC on CI8 column was 
employed for the purification of the chymotrypsin inhibitor. 
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1.3 Materials and methods 
1.3.1 Materials 
Momordica cochinchinensis seeds were bought from a local market and 
stored in a cool dry place before use. a-Chymotrypsin (type II form porcine 
pancreas), trypsin (type IX from porcine pancreas), elastase (type IV form 
porcine pancreas), subtilisin (type XXVII) and substrates used in enzyme 
assays including Na-benzoyl-L-tyrosine ethyl ester (BTEE), 
Na-benzyol-L-arginine ethyl ester (hydrochloride) (BAEE), 
N-succinyl-Ala-Ala-Pro-Phe-p-nitroamlide(sAAPFpNA),N-succinyl-Ala-Al 
a-Ala-p-nitroanilide(STANA) and p-nitrophenyl acetate (NPA), disposable 
filter units with luer fitting (0.45 |im pore size), trifluoroacetic acid (TFA) 
and bicinchoninic (BCA) were all bought from Sigma Chemical Co. 
Molecular weight polypeptide standards and reagents for electrophoresis 
were purchased from Bio-Rad, California, U.S.A. Cyanogen bromide 
. (CNBr)-activated Sepharose 4B was purchased from Amersham Pharmacia 
Biotech. SpectraPor 6 dialysis membrane (MWCO 1,000) was obtained 
I 
from Spectrum Medical Industries, Inc., California, U.S.A. Prep 
Nova-Pack HR CI8 HPLC Column (Dimethyloctadecylsilyl bonded 
9 
amorphous silica, 6[im, 60人，internal diameter 19 x 300 mm) was 
purchased from Waters Corporation, Milford, Massachusetts, U.S.A. GVWP 
filters (0.22 |am) were products of Millipore, Micron Separations Inc. 
Solvents for HPLC, including acetonitrile and methanol, were products of 
either BDH Laboratory Supplies, Poole, England or Merck, Darmstadt, 
Germany. Milli-Q water was produced by the water purification system of 
Millipore, U.S.A. Disposable filter unit of 0.22 |im pore size with luer 
fitting (Cameo 25AS, acetate, sterile, non-pyrogenic) was a product of 
Micron Separation Inc. All other chemicals were of analytical grade and 
were used without further purification. 
1.3.2 Preparation of chymotrypsin-Sepharose 4B affinity column 
Chymotrypsin was coupled to CNBr-activated Sepharose 4B following the 
protocol provided by Amersham Pharmacia Biotech. Seven gram of 
- freeze-dried gel powder were swollen, washed with 1.4 litres of 1 mM HCl 
to give 25 ml gel and then equilibrated with two column volumes of 
coupling buffer. After that, 233 mg bovine chymotrypsin was dissolved in 
35 ml coupling buffer (0.5 M NaCl in 0.1 M NaHCOs, pH 8.3) and added to 
, 10 
the gel. The mixture was mixed by rotating end-over-end for 90 min. It 
was then washed with five column volumes of coupling buffer to wash out 
the unbound chymotrypsin. After washing the gel with two column volumes 
of blocking buffer (0.1 M Tris-HCl, pH 8.0)，the gel was incubated with 100 
ml blocking buffer for 120 min at room temperature to block any remaining 
reactive groups. The product was then washed with three cycles of 
alternating pH buffer (0.5 M NaCl in 0.1 M sodium acetate, pH 4.0 and 0.5 
M NaCl in 0.1 M Tris-HCl, pH 8.0)，with five column volumes of each 
buffer. Finally, it was equilibrated with the equilibration buffer, 0.05 M 
Tris-HCl, pH 8.0, and was then ready for use. 
1.3.3 Protein extraction 
About 138 g of decorticated seeds were soaked in 3 M NaCl, 0.05 M Tris-Cl, 
pH 8.0. After incubation at 4°C overnight, the seed was homogenized in a 
- blender and centrifuged at 12,000 g (Beckman model J2-21) for 60 min at 
4°C. The pellet was discarded and the supernatant was passed through two 
layers of cheesecloth to remove any large particles. The extract was then 
ready for further purification. 
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13.4 Chymotrypsin-Sepharose 4B affinity chromatography 
Chymotrypsin-Sepharose 4B affinity chromatography was performed under 
the control of the Biologic LP system. The crude extract was dialyzed 
overnight against 3 M NaCl, 0.05 M Tris-Cl, pH 8.0. Afterward, the 
dialyzed extract was added to the chymotrypsin-Sepharose 4B affinity 
column (15 X 120 mm) pre-equilibrated with the equilibration buffer (3 M 
NaCl, 0.05 M Tris-HCl, pH 8.0). After washing with two column volumes 
of equilibration buffer to remove unbound proteins, 0.05 M HCl were 
applied to elute the bound proteins at a flow rate of 0.7 ml/min. The 
fractions with strong chymotrypsin-inhibitory activity were pooled and 
dialyzed overnight against 4 x 4 1 Milli-Q water. The dialyzed sample was 
then lyophilized and ready for further purification. 
1.3.5 Reversed phase high pressure liquid chromatography 
/ 
(RP-HPLC) 
The lyophilized sample was dissolved in 1 ml 12 % acetonitrile with O.l % 
trifluoroacetic acid (TFA). It was centrifuged at 12,000 g (BioRad 
‘ 12 
centrifuge 5417R) at 4°C for 15 min and any insoluble pellet was discarded. 
Then the sample was ready for RP-HPLC run under the control of AKTA 
Purifier HPLC system (Amersham Pharmacia Biotech.). In this 
chromatography, all solvents used were of HPLC grade and the water used 
was Milli-Q water after passing through a 0.22 \im GVWP filter fitted to a 
bottle top filter, all solvents were degassed for 15 min by using an ultrasonic 
cleaner (Branson 2210) before being used. 
After the sample was applied to a Prep Nova-Pack HR C18 column (Waters 
19 X 300 mm) pre-equilibrated with 12 % acetonitrile with 0.1 % TFA, the 
column was washed with one column volume of equilibration buffer. Then 
two consecutive linear gradients, 12 % to 27 % of acetonitrile with 0.1 % 
TFA for 10 min, followed by 27 % to 39 % of acetonitrile with 0.1 % TFA 
for 90 min were applied. The flow rate was 3 ml/min. The peaks with 
chymotrypsin-inhibitory activity were pooled. After dialysis against 
Milli-Q water overnight, the sample was lyophilized. The sample 




1.3.6 Assays for protease inhibitory activities 
To determine the inhibitory activity against different proteases, 10 \i\ of test 
sample was added to the proteases in assay buffer (50 mM Tris-HCl with 20 
mM CaCl2,pH = 8.0). To ensure the inhibitor had reached equilibrium of 
binding to the protease, the reaction mixture was incubated for 15min at 
room temperature before the substrate was added to initiate the reaction. 
The inhibitory activity was then calculated as the difference between 
protease activity in the presence and the absence of the inhibitor. One unit 
of inhibitory activity refers to the inhibition of one mg of serine protease. To 
improve the accuracy of measurement, the amount of inhibitor in the assay 
was adjusted to give a 30-70% inhibition of protease activity. 
Calculation: 
Inhibitory activity(U) = (AbScontroi - Abssampie) / AbScontroi x Protease (mg) 
where Abscontroi and Abssampie are the rates of the absorbance change in the 
absence and presence of inhibitor respectively; 
Protease is the amount of serine protease in the assay mixture. 
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1.3.6.1 Assay for chymotrypsin activity 
Chymotrypsin activity was determined as desribed in Shabata et al (1986) 
with some modifications. Ten microliter of 0.1 mg/ml a-chymotrypsin 
solution was added to 490 [d of assay buffer (50 mM Tris-HCl with 20 mM 
CaCb’ pH = 8.0). The reaction was started by adding 500 |il of BTEE in 
assay buffer with 10 % methanol to give a final concentration of 0.5 mM. 
Absorbance change was then measured at 253 nm for 1 min using an 
Ultraspec 3000 UV/VIS spectrophotometer. 
1.3.6.2 Assay for trypsin activity 
, Trypsin activity was also determined as described in Shibata et al, (1986) 
with slight modifications. Ten microliter of 0.25 mg/ml trypsin was added to 
980 [i\ assay buffer and then 10 \i\ ofBAEE in the same buffer was added to 
give a final concentration for 0.6 mM. .The reaction rate was determined by 
monitoring the absorbance change at 253 nm for 1 min. 
15 
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1.3.6.3 Assay for elastase activity 
Elastase activity assay was done by using a synthetic ester, 
N-succinyl-Ala-Ala-Ala p-nitroanilide (STANA), as substrate. Ten 
microliter of a 0.1 mg/ml elastase solution was added to 790 |j.l of assay 
buffer. Then 200 fil of STANA was added to give a final concentration of 2 
mM. Absorbance change at 385 nm was monitored. 
1.3.6.4. Assay for subtilisin activity 
Subtilisin activity was also determined by using the synthetic ester STANA 
as substrate. Ten microliter of a 3 mg/ml subtilisin solution was added to 
690 [i\ of assay buffer. After that, the reaction was started by adding 300 |j,l 
of STANA to give a final concentration of 3 mM. The reaction rate was 
determined by monitoring the change of absorbance at 385 nm for 1 min. 
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1.3.7 Determination of protein concentration 
Protein concentration of the samples and proteases used in the assays was 
determined by using bicinchoninic acid (BCA) following the protocol 
provided by Sigma Chemical Co. Bovine serum albumin (BSA) was used as 
the standard. A working solution was made up by mixing 50 volumes of 
BCA solution with 1 volume of 4% (w/v) solution of copper (II) sulfate 
pentahydrate solution. After mixing 20 |il of sample with 1 ml of working 
solution, the reaction mixture was incubated at 37 °C for 30 min. Then the 
reaction mixture was allowed to stand at room temperature for 10 min 
before the absorbance at 562 nm was measured. 
1.3.8 Titration of chymotrypsin 
To know the concentration of active chymotrypsin used in the assay, 
titration was done by using p-nitrophenyl acetate (NPA). Fifty of 
different concentrations of chymotrypsin was added to 850 |il of 0.1 M 
sodium phosphate, pH 7.5. The substrate NPA with 0.1 % methanol was 
added to start the reaction. Absorbance change at 400 nm was monitored 
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for 200 sec. The active concentration of chymotrypsin was calculated from 
the burst phase using a molar extinction coefficient (S4oonm) of 16 mM"^  cm"^  
for p-nitrophenol. A plot of the active concentrations of chymotrypsin 
against the protein concentrations of the chymotrypsin calculated by using a 
molar extinction coefficient (eigonm) of 4.9 x lO'^ M"^  cm"^  for soluble bovine 
chymotrypsin at 280 nm (Gabel, 1974) was constructed. The slope gave the 
percentage of active chymotrypsin in the assay. 
1.3.9 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
The method of sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) with a tricine buffer system was adopted from Schagger and 
von Jagow (1987) using a 16.5 % separating gel, a 10 % spacer gel and a 4 
% stacking gel. The gel was cast on the Mini-Protean set II (Bio-Rad). 
Samples and standards were diluted with the sample loading buffer (24 % 
glycerol, 1 % SDS, 0.02 % bromophenol blue and 2 % (v/v) 
P-mercaptoethanol in 0.1 M Tris-HCl, pH 6.8) and boiled in a water bath for 
15 min. The cathode buffer was 0.1 % SDS in 0.1 M Tricine, 0.1 M Tris, 
pH 8.25 while the anode buffer was 0.2 M Tris-Cl, pH 8.9. Electrophoresis 
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was started at a constant voltage of 30 V at room temperature. Once the 
dye front reached the spacer gel, the voltage was increased to 100 V until 
the end of the electrophoresis. When the tracking dye, bromophenol blue, 
reached the bottom of the gel, electrophoresis was stopped. 
The gel was stained according to the protocol which came with the 
SDS-PAGE molecular weight polypeptide standards provided by Bio-Rad. 
The gel was first fixed by immersing in polypeptide fixative solution (10 % 
acetic acid and 40 % methanol) for 35 min. Then the gel was stained with 
Coomassie Blue G-250 staining solution (0.025 % Coomassie Blue G-250 
in 10 % acetic acid) for 60 min. Lastly, the gel was destained in 10 % acetic 
acid for 90 min until the background was clear. 
1.3.10 Determination of molecular weight by mass spectrometry 
The molecular weight of the purified MCCI was determined by mass 
spectrometry performed at the laboratory of the Molecular Biology 
Resource Facility in the William K. Warren Medical Research Institute 
(WMRI), The University of Oklahoma Health Sciences Center, USA, using 
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Perkin-Elmer-Sciex API III triple-quadrupole mass spectrometer equipped 
with an electrospray ionization source which can be used to produce either 
positive or negative ions. 
1.3.11 Partial amino acid sequencing 
MCCI was partially digested with lysyl endopeptidase in 20 mM CaCli, 50 
mM Tris-Cl, pH 8.0 at 37 °C for 4 hr. Peptide mixture resulting from 
enzymatic digestion was resolved on a HPLC system using a reverse phase 
CI8 column. The peptides were eluted with a linear gradient of 12-39 % 
acetonitrile, with 0.1% TFA. One of the peaks (eluted at 33.5 min) was 
submitted for amino acid sequence analysis at the Molecular Biology 
- Resource Facility in the William K. Warren Medical Research Institute, The 
University of Oklahoma Health Sciences Center, USA. The N-terminal 
amino acid sequencing was carried out using a Perkin-Elmer, Applied 
Biosystem Division, procise model 492 equipped with an on-line 
PTH-amino acid analyzer and model 61 OA data system. 
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1.3.12 Effects of chymotrypsin on MCCI 
MCCI (100 |ig/ml) was incubated with chymotrypsin (100 |ig/ml) in 0.05 M 
Tris-Cl and 20 mM CaCb, pH 8.0 for 24 hr at room temperature. The 
resultant mixture was then analyzed by SDS-PAGE. 
1.3.13 Stability assay 
The stability of MCCI at different pH values was studied by incubating the 
inhibitor in buffers of various pH for 2 hr. Then an aliquot was removed for 
chymotrypsin-inhibitory activity assay. To study the thermostability, MCCI 
was incubated at 100 Aliquots were removed at intervals for the 
- chymotrypsin-inhibitory activity assay. 
1.4 Result 
1.4.1 Isolation of MCCI from the seeds of Momordica cochinchinensis 
The chymotrypsin inhibitor (MCCI) from the seeds of Momordica 
cochinchinensis was extracted with 3M NaCl in 0.05 M Tris-Cl buffer. This 
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extraction procedure was followed with affinity chromatography on 
immobilized chymotrypsin on a Sepharose-4B column. Affinity 
chromatography of the crude extract on chymotrypsin-Sepharose 4B yielded 
a large unadsorbed peak and a smaller adsorbed peak (Figure 1.1). The 
unadsorbed fraction had strong trypsin-inhibitory activity but little 
chymotrypsin-inhibitory activity, whereas the adsorbed fraction possessed 
strong chymotrypsin-inhibitory activity, but little trypsin-inhibitory activity. 
SDS-PAGE analysis showed that most of the contaminating proteins were 
removed by the affinity chromatography (Figure 1.2). The final trace of 
contaminants was removed by reverse phase HPLC on a CI8 column. Two 
adsorbed peaks, both with chymotrypsin-inhibitory activity, were obtained 
(Figure 1.3). The second peak, eluted at 34% of acetonitrile, was more 
potent and was thus taken for further characterization. The homogeneity 
of this preparation was confirmed by the presence of a single band on 
SDS-PAGE (Figure 1.2). From 138 g of seeds, 1.44 mg of MCCI can be 
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Figure 1.1 Affinity chromatography of the crude extract on 
chymotrypsin-Sepharose 4B. The crude extract of Momordica 
cochinchinensis seeds was dialyzed against 3M NaCl, 0.05 Tris-Cl pH 8.0 
and then loaded onto a chymotrypsin-Sepharose 4B column (15 x 150 mm) 
pre-equilibrated with the dialysing buffer. After washing, the column was 
eluted with 0.05 M HCl. The flow rate was 0.7 ml/min and the fraction size 
was 1.2 ml. The fractions was assayed for chymotrypsin-inhibitory activity 
(U/ml) ( • ) as well as trypsin-inhibitory activity ( • ) . 
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Figure 1.2 SDS-PAGE analysis. Lane 1, crude extract; lane 2, eluate 
from the affinity chymotrypsin-Sepharose 4B column; lane 3，eluate from 
the HPLC CI8 column (MCCI). 
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Figure 1.3 Reversed phase high pressure liquid chromatography of 
the affinity-eluate on C18. The affinity-chromatography eluate containing 
chymotrypsin-inhibitory activity was, after dialysis, loaded to a CI8 
column (19 x 300 mm) equilibrated with 12 % acetonitrile and 0.1 % TFA. 
After the column was washed with one column volume of equilibration 
buffer, two consecutive linear gradients, 12% - 27 % of acetonitrile with 
0.1% TFA for 10 min, followed by 27 % - 39 % of acetonitrile with 0.1% 
TFA for 90 min were applied. The flow rate was 3ml/min and the fraction 
size was 1.5 ml/min. The peak with strong chymotrypsin-inhibitory 
activity ( • ) was pooled ( 卜 ) . 
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Table 1.1 Summary of purification of a chymotrypsin-specific inhibitor, 
MCCI, from Momordica cochinchinensis. 
Amount of Inhibitory~I Specific iPurification 1 Percentage 
protein (mg) Activity (U) Inhibitory Fold Yield (%) 
Activity 
l ( U / m g )   
^ [T^ 118.10 [oT^ [i 
AF-MCCI 1.63 ^ J J l ^ ^ 
HPLC l 4 4 531 4L2 413 
-MCCI _ J  
From 138 g of decoated seeds. 
CE : Crude Extract 
AF-MCCI: Eluate from the chymotrypsin-Sepharose 4B affinity column 
HPLC-MCCI: Eluate from the CI8 HPLC column 
, 26 
1.4.2 N-terminal amino acid sequencing 
N-terminal amino acid sequencing of native MCCI by the usual Edman 
degradation method failed to yield any sequence, thereby suggesting a 
blocked amino terminus. To obtain some sequence information, MCCI was 
digested with lysyl endopeptidase and the digest could be separated into 
several peaks on reverse phase HPLC (Figure 1.4). The peptide from the 
peak at the elution time of 33.5 min was successfully sequenced for 23 
amino acid residues (Table 1.2). Comparison of the determined sequence 
with other protease inhibitors showed that the greatest identity was with the 
potato I protease inhibitor. In this region, MCCI exhibited a sequence 
identity of 82.6% and 60.9% with BGIA (from the bitter gourd Momordica 
charantia) and CMTI-V (from the pumpkin Cucurbita maxima) respectively. 
Sequence identity with potato I protease inhibitors from other families is, 
however, much less, being 43.5%, 30.4%, 21.7% and 34.8% with PC-1 
(from potato), eglin (from leech), CI-1 (from barley) and CI-2 (from barley) 
respectively (Table 1.2). 
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Figure 1.4 RP-HPLC elution profiles of (A) native MCCI, and (B) 
peptides generated from MCCI by lysyl endopeptidase. The column used 
was a CI8 column and a linear gradient of 12-39 % acetonitrile with 0.1% 
TFA was used (x-axis: elution time; y-axis: absorbance at 214 nm). 
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Table 1.2 Partial amino acid sequence of MCCI. 
M C C I [ B ^ | C M T I - V |MCI-3[PC^ |Eglin-C |CI-1 
from from from from from from from 
bitter pumpkin bitter potato leech barley barley 
gourd gourd  
A A A E E E K 
V V i L I Y i V 
I i I V i F I i 
Q E 1 E 1 T L L 
R R R R K L R Q 
E E Q E Q H D D 
N N N N N Y K K 
P P P P S P P P 
^ R N R L Q N E 
V V V V I Y A A 
R R K R S D Q Q 
A A A A N V I I 
V V V V Y E I 
H  
I i I i F V V 
L V L L L I L 
‘ Q R E L P P P 
V V E N E V V 
G G ^ G G D G 
S S T S S A T 
P P P P P M I 
V V V V V V V 
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L A K M L L M 
The MCCI partial amino acid sequence was aligned with the sequences of 
BGIA (inhibitor of acidic amino acid-specific endopeptidase of 
Streptomyces griseus from bitter gourd, MCI-3 (trypsin inhibitor from bitter 
gourd, CMTI-V (trypsin and hageman factor inhibitor from pumpkin, PCI 
(chymotrypsin inhibitor from potato), eglin-C (inhibitor from leech), CI-1 
(chymotrypsin inhibitor from barley) and CI-2 (chymotrypsin inhibitor from 
barley). Bold type letters indicate residues that are identical with those in 
MCCI. 
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1.4.3 Determination of molecular weight 
From the result of mass spectrometry (Figure 1.5), there is one major signal 
identified at a mass to charge ratio of 7,514 which corresponds to the single 
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Figure 1.5 Determination of the molecular weight of MCCI from mass 
Spectrometry. 
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1.4.4 Inhibitory activity of MCCI towards different proteases 
The specific inhibitory activity (U/mg) of MCCI towards different serine 
proteases is shown in Table 1.3. MCCI showed a strong inhibition on 
chymotrypsin with a specific activity of 5.3 U/mg, regardless of the 
substrate (BTEE or Suc-AAPF-pNA) used to follow the activity. It also 
strongly inhibited the activity of subtilisin, but its inhibitory activity towards 
trypsin and elastase was at least 50-fold lower. 
To determine the binding ratio between MCCI and chymotrypsin, the active 
percentage of chymotrypsin used in the assay was first determined, using 
the substrate NPA. The reaction between chymotrypsin and NPA entered 
into a steady-state phase after the reaction had started for about 10 sec 
(Figure 1.6). The extrapolated y-intercept in the progress curve represents 
the active chymotrypsin amount. A plot of the active chymotrypsin content 
against chymotrypsin amount in the assay is shown in Figure 1.7. The slope 
of the curve was 0.79, indicating that the active percentage of soluble 
chymotrypsin used in the assay was 79 %. The residual chymotrypsin 
activities at different concentrations of MCCI were then assayed. The ratio 
‘ 33 
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Table 1.3: Inhibitory activity of MCCI for several serine proteases. 
Protease I Substrate I Specific Inhibitory activity (U/mg) 
Chymotrypsin BTEE 5.32 
Suc-A-A-P-F-pNA “ 
Trypsin BAEE 0.0012 
Elastase STANA 0.097 
Subtilisin STANA 5.65 
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Figure 1.7 Plot of active concentration of chymotrypsin against the 
total concentration of chymotrypsin in the assay mixture. The active 
concentration of chymotrypsin was calculated from the burst phase in the 
progress curve (Figure 1.6) while the total concentration was determined 
from the absorbance at 280 nm. 
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of MCCI to active chymotrypsin was calculated by extrapolating the linear 
range to the X-intercept in the plot of the residual protease activity against 
different ratio of MCCI against protease. It was found that each MCCI 
molecule bound two active chymotrypsin molecules (Figure 1.8). 
1.4.5 Effects of chymotrypsin on MCCI 
The proteolytic activity of chymotrypsin on MCCI was investigated. 
Incubation of chymotrypsin with its inhibitor MCCI did not result in the 
generation of any additional bands upon SDS-PAGE analysis (Figure 1.9), 
suggesting that there was no cleavage of MCCI by chymotrypsin under the 
present experimental condition. 
1.4.6 Stability of MCI on heating and at different pH 
MCCI was stable even after prolonged heating. About 20 % inhibitory 
‘ activity of MCCI was lost after boiling for 5 hr (Figure 1.10). MCCI was 
also stable at a wide range of pH conditions. There were only 8% and 14 % 
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Figure 1.8 The residual chymotrypsin activity in the presence of 
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Figure 1.9 SDS-PAGE analysis. Lane 1, bovine a-chymotrypsin; lane 2， 
mixture of chymotrypsin and MCCI after 24-hr incubation at room 
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Figure 1.10 Stability of MCCI on heating in boiling water. At different 
incubation time interval, 10 |il of MCCI solution (in distilled water) was 
removed for chymotrypsin-inhibitory activity assay. Each value represents 
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Figure 1.11 Stability of MCCI at different pH environment. MCCI 
was incubated at different pH for 2 hr before an aliquot was taken for 
'activity assay. The remaining activity at pH 8.0 was taken as 100%. Each 
value represents the mean of two separate determinations. 
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1.5 Discussion 
Isolation of MCCI 
In this study, affinity chromatography was used instead of ion-exchange 
chromatography as the first step of purification because of its higher 
specificity and yield. By the enlightening fact that high salt concentration up 
to 3 M NaCl could enhance the interaction between chymotrypsin and its 
inhibitors (Wesolowska et a!., 2001), the purification of the chymotrypsin 
inhibitor by the affinity column was performed under such a high salt 
condition, thus, the washing buffer used was 3 M NaCl in 0.05 M Tris-Cl, 
pH 8.0. It has been reported that protease inhibitors purified by the affinity 
column may be inactivated by proteolytic cleavage, as demonstrated in the 
purification of chick ovoinhibitor (Feinstein and Gertler, 1972), inhibitors 
from chick peas (Belew et al., 1977) and protease inhibitor from flax seeds 
(Lorenc-Kubis et ai, 2001). The modification of the inhibitor by the 
immobilized enzyme could be avoided in the present procedure as the high 
salt condition of 3 M NaCl was shown to be effective in protecting the 
reactive-site peptide bond in the purification of trypsin inhibitors from 
Cucurbitaceae family seeds (Wilimowska-Pelc et al., 1999). After this 
single affinity step, the specific activity of the preparation increased by more 
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than 40 fold, much higher than the 4 fold achieved by the ion exchange 
chromatography on the SP-Sepharose (Wong, 2001). 
Identification of MCCI as a potato I inhibitor 
Momordica cochinchinensis belongs to the family of Cucurbitaceae where a 
large number of protease inhibitors have been isolated. The majority of 
them are squash family inhibitors with a molecular weight around 3,500 
(Huang et al.’ 1999). Mass spectrometry of MCCI isolated from the present 
study gave a molecular weight of 7,514, which is much higher than that 
expected for a squash family protease inhibitor. The belief that MCCI is 
not a squash family inhibitor is supported by the observation that its 
inhibitory activity was resistant to treatment with dithiothreitol and 
iodoacetic acid (data not shown), suggesting that the activity may not be 
dependent on the presence of disulfide bonds. Among the common 
‘ protease inhibitor families, only potato I inhibitors are known to be 
functionally independent of the presence of disulfide bridges in their 
structures (MacPhalen et al, 1985). This, together with the fact that the 
potato I protease inhibitor usually has a molecular mass around 6,000 to 
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8,000 Da, suggests that MCCI was a potato I family inhibitor. 
To confirm the assignment of MCCI as a potato I inhibitor, amino acid 
sequencing was carried out by using automated Edman degradation. In the 
first trial for N-terminal amino acid sequencing of native MCCI, it fails to 
yield any results. It may be attributed to the presence of a blocked 
N-terminus as such modification is common in the proteins of seeds 
(Persson et a/., 1985). Some sequencing data was successfully obtained from 
a fragment of MCCI generated from the cleavage by lysyl endopeptidase, 
which revealed its homology with other potato I protease inhibitors. Of the 
23 amino acid residues sequenced for MCCI, 19 were found to be identical 
with BGIA isolated from Momordica charantia (Ogata et al., 1991). 
Another potato I inhibitor, MCI-III, has also been isolated from Momordica 
charantia (Zeng et al； 1988). It is interesting to note that while MCI-III 
shows a high degree of homology with BGIA for the 23 amino acid residues 
at the C-terminal of the molecules, there is little or no homology at other 
regions. Similarly, the MCCI partial sequence did not show any homology 
with MCI-III at the same region (from amino acid residue 22 to 45, based on 
the numbering in BGIA). Quite unexpectedly, it shows a high degree of 
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homology with another region of MCI-III. Eight out of 11 amino acid 
residues of MCCI (from position 22 to 33) were identical to the sequence of 
a peptide P5 from the peptic digests of MCI-III which was mapped to 
positions 37 to 47 in the MCI-III sequence. The full-length sequence of the 
inhibitor is obtained by overlapping the sequence of various peptides. In 
MCI-III, the possibility that there is an error in the assignment of the peptide 
order cannot be ruled out, especially when there are two highly similar 
regions, RENPRVRA and REDPSVRA in the sequence (Zeng et al.’ 1988). 
A re-evaluation of the MCI-III sequence may show a higher degree of 
homology with other potato I family inhibitors. 
Thus, MCCI is a member of potato I protease inhibitor. MCCI was further 
confirmed to be in the potato I family because of its N-terminus 
modification which is supposed to be a general feature for inhibitor in this 
family (Krishnamoorthi et al, 1990; Ogata et al, 1991; Lorenc-Kubis et al., 
‘ 2001). Such modification is not important for the inhibitors' defensive 
function to protect plants against insects and pathogens. It is possible that 
plant protease inhibitors play multiple roles, rather than only the inhibition 
of proteolytic enzymes. Products of proteolytic degradation of the inhibitors 
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have been detected in the process of germination and may perform 
important regulatory functions. Such functions might depend on whether the 
peptides have blocked or free N-termini (Pellegrini et al, 1996). 
Characterization of MCCI 
MCCI could strongly inhibit subtilisin and chymotrypsin, however, its 
inhibitions against elastase and trypsin were extremely weak. Most of the 
known protease inhibitors in the potato I family are usually trypsin-specific, 
for example LUTI from common flax seeds (Lorenc-Kubis et al, 2001), 
BWI-4a from buckwheat seeds (Belozersky et al., 2000) and a protease 
inhibitor from pumpkin seeds (Krishnamoorthi et ai, 1990). In 
Cucurbitceae, three potato I inhibitors have been reported. BGIA and 
MCI-III are isolated from Momordica charantia and act on trypsin and 
acidic amino acid-specific endopeptidase of Streptomyces griseus 
, respectively (Ogata et al, 1991; Zeng et al,, 1988). The other potato I 
inhibitor from Cucurbitaceae, CMTI-V isolated from pumpkin, inhibits 
trypsin and activated Hageman factor (Krishnamoosthi et al., 1990). None 
of them have any effect on chymotrypsin. To our knowledge, MCCI was the 
46 
first chymotrypsin-specific inhibitor isolated from the Cucurbitaceae family. 
Protease inhibitors specific to chymotrypsin would also act on subtilisin, for 
example, the potato I chymotrypsin inhibitor CI-I and CI-II isolated from 
barley (Svendsen et al, 1982). Chymotrypsin shares a similar proteolytic 
mechanism as subtilisin. While chymotrypsin can only cleave the peptide 
bond with aromatic or bulky non-polar side chain on the carboxyl side, 
subtilisin is less specific and cleave all the peptide bonds with non-polar 
side chain on the carboxyl side. Therefore, when an inhibitor can inhibit 
chymotrypsin, it usually can inhibit subtilisin but not vice versa, i.e. 
subtilisin inhibitor cannot inhibit chymotrypsin (Vartak et al.’ 1980). 
Different serine protease inhibitors from different sources have different 
binding ratio to their corresponding proteases. For example, the molar ratio 
ofKunitz inhibitor to its cognate protease is usually 1:1 (Souza et al, 1995). 
It was noted that MCCI inhibited chymotrypsin at a molar ratio of 1:2 
‘ instead of 1:1. In this regard, it is of interest to note that a winged-bean 
chymotrypsin inhibitor also inhibit chymotrypsin at a ratio of 1:2. Such 
result can be explained by the cooperativity action, giving rise to the 
secondary reactive site in the Kunitz inhibitor (Ghosh and Singh, 1996). On 
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the other hand, a binding ratio of 1:2 for MCCI to chymotrypsin could also 
be attributed to the presence of two different reactive sites on the inhibitor 
which is common in the Bowman-Birk inhibitor (Song et al” 1999; Brauer 
et al., 2001). Further structural characterization is needed to clarify the 
issue. 
Protease inhibitors and proteases interact with each other. The inhibitor will 
try to inhibit the protease while, at the same time, the protease will try to 
cleave the inhibitor. The inhibitor may not be able to completely inhibit the 
proteolytic activity of the protease and thus might be broken down by the 
protease. It has been shown that some protease inhibitors, known as 
temporary inhibitors, could be digested by its corresponding protease 
(Wilimowska-Pelc et al., 1999). The presence of proteolytic product of the 
inhibitor after affinity chromatography through the immobilized protease 
column is also a direct demonstration of the effect of the protease on the 
inhibitor. In the present study, MCCI purified from the seeds of 
Momordica cochinchinensis were not digested by chymotrypsin up to 24 hr 
I 
incubation, as shown by the result of SDS-PAGE (Figure 9), suggesting that 
MCCI was not a temporary inhibitor. 
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In addition to its high resistance against chymotrypsin, MCCI was also 
stable on heating and at extreme pH, e.g. 2 or 12. MCCI showed a rather 
high stability in different harsh physical environments. Such stability of 
protease inhibitors is generally believed to be related to their physiological 
role against proteolysis of invasion by other organisms (Okagawa et al., 
1994). The unusual stability of a chymotrypsin inhibitor (CI-2) of potato I 
family has been extensively investigated (Mikola and Mikkonen, 1999; 
Kortt, 1980) and such stability is suggested to be related to the specialized 
structure of the active site of the inhibitor. The conformation of the 
reactive site loop of CI-2 is stabilized by a network of hydrogen bonds and 
electrostatic interactions. As shown by X-ray crystallography, the side 
chains of Arg65 and Arg67 extend toward the loop from the p-sheet, 
providing most of the contacts between the loop and the body of the 
inhibitor. The electrostatic and hydrogen-bonding interactions that these 
- side chains make with residues on either side of the scissile bond could 
. contribute to prevent the formation of new termini of a hydrolyzed reactive 
bond from other external reactive process, e.g. the acid-catalyzed hydrolysis. 
The side chains of these arginine residues are highly ordered, partly because 
they are buried, closely-packed and come from the central strand of the 
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parallel p-sheet in the molecule. This well-organized structure is only found 
in the potato I inhibitor so far and such structure could only be established 
in the absence of disulfide bond in the active site which is a characteristic of 
potato I inhibitor. The stability of MCCI might also come from similar 
structure, although further experiments are obviously needed. Besides, the 
property of high stability may also be further explained by its low molecular 
weight which allows a more compact folding of the polypeptide. As MCCI 
was generally stable in different physical environments, including extreme 
pH and high temperature, the physiological effect of MCCI in the seeds of 
Momordica cochinchinensis is likely to be preserved even after the 
traditional application of Momordica cochinchinensis for curing heals on 
skin, for example, by applying the resultant products after boiling in ethanol 
or ingestion after boiling in water. 
To sum up, a chymotrypsin-specific protease inhibitor, MCCI, with a 
molecular weight of 7,514 was purified from the seeds of Momordica 
cochinchinensis. Partial amino acid sequence analysis showed that it was a 
potato I inhibitor. MCCI showed very high stability at extreme pH and after 
boiling at 100 T . 
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Chapter 2 Immunomodulatory effect of MCCI 
2.1 Introduction of the immune system and protease inhibitors 
The relationship between protease inhibitors and immune cells is very close 
and the action is cell-specific. In T cell development, the inducible 
expression of cytokine mRNA is controlled mainly by transcriptional 
activators such as nuclear factor KB (NFKB) (Sivakumer et al., 2003; 
Weitzman et al., 2001). The activation of NFKB is a multistep process. In 
quiescent cells, NFKB exists as a ternary complex with the inhibitory subunit 
IKB-a. Upon T cell activation, IKB is rapidly phosphorylated and dissociates 
from' the trimer, leading to the appearance of the NFKB heterodimer 
(Weitzman et al., 2001). IKB degradation is mediated by a chymotrypsin-like 
enzyme that can be inhibited by irreversible serine protease inhibitors such as 
"-tosylphenylalanine chloromethyl ketone (TPCK). Moreover, serine 
proteases are also involved in the early events of lymphocyte proliferation 
. and IL-2 production which play a key role in the different stages of cell 
growth. Such processes are known to be blocked by serine protease inhibitors 
(Tchorzewski et al., 1995). 
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Protease inhibitors can prevent the production of superoxide anion radicals 
and H2O2 in neutrophils stimulated by tumor-promoting agents (Wright et al.’ 
1999). In addition, protease inhibitors are also believed to play a role in the 
normal functioning of different immune cells, in particular, neutrophils and 
macrophages (Jin et al., 1997). Excess proteolytic activity is thought to play 
a major role in the destruction of body tissue, such as in emphysema. 
Consequently, there are numerous medical investigations in search of 
protease inhibitors that can antagonize this protease-associated pathological 
condition. While the clinical value of protease inhibitors was emphasized by 
numerous scientists, there is an opposing voice from some research groups. 
Campman and Stone (1984) found that soybean trypsin inhibitor (SBTI) 
inhibited the elastolytic activity of normal phagocytic cells and resulted in 
cell-killing. This was supported by Jin et al., (1987) who claimed that an 
ovomucoid trypsin inhibitor could destroy normal phagocytes. The effect of 
different protease inhibitors on the different types of cells and the normal 
/ 
functioning of the immune system were advocated in the last decades 
(Wright et al., 1999; Smith et al., 2002). The mystery of the roles of protease 
inhibitors in immune system may soon be disclosed. 
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Among the different types of protease inhibitors, serine protease inhibitor is 
the most extensively investigated one. The studies on serine protease 
inhibitor cover a wide variety of cells in immune system, including 
lymphocytes, bone marrow cells, neutrophils and macrophages. 
Neutrophils response to infection in vivo is initiated by adherence of the 
neutrophils to vascular endothelia, progress to the directed migration of the 
neutrophils into the extravascular tissue space, and culminates in 
neutrophil-mediated phagocytosis and intracellular killing of the invading 
micro-organisms. During phagocytosis or on exposure to soluble agonists, 
neutrophils exhibit a marked increase in oxidative metabolism. This response, 
known as the respiratory burst, is mediated by activation ofNADPH oxidase 
and results in the formation of superoxide anion (O2 ) as well as hydrogen 
peroxide (H2O2) and other reactive species. An In vitro experiment showed 
, that the production of superoxide anions can be modulated by human 
. secretory leukocyte protease inhibitor (SLPI) from mucosal epithelial cells 
through interacting strongly with human neutrophil serine proteases (Junger 
et al, 1992; Wright et al, 1999). 
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At the beginning of the 1970s, a group of scientists found that there were two 
major proteolytic activities in macrophages which could be strongly inhibited 
by the corresponding inhibitor. The hemoglobin-hydrolyzing activity at pH 
4.0 was strongly inhibited by pepstatin, a pepsin inhibitor. The caseinolytic 
activity at pH 7.0 was sensitive to chymostatin, a chymotrypsin inhibitor. In 
addition, other chymotrypsin-like enzymes were also found in macrophages 
(Kato et al” 1972). Later, Nagai et al (1978) reported that chymotrypsin or 
chymotrypsin-like proteases may also be involved in the phagocytosis of 
macrophages. Some serine protease inhibitors were found to reduce the 
locomotion of inflammatory macrophages (Villi et al.’ 1987) and some 
epithelial protease inhibitors were believed to modulate the formation of the 
action products of macrophages, i.e., nitric oxide and TNF-a (Jin et al, 
1997). 
To confirm the relationship between serine protease inhibitor and 
macrophage, macrophages were transfected with a secretory leukocyte 
protease inhibitor (SLPI) gene (Sano et al, 2002). It was found that SLPI 
could suppress LPS-induced activation of NF-jB, causing a decrease in the 
. ‘ production of TNF-a and the expression of inducible nitric oxide synthase 
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(iNOS), thereby lower NO production. On the basis of these findings, it was 
proposed that LPS-hyporesponsiveness of macrophages is due principally to 
the overexpression of SLPI. Thus, SLPI was believed to be involved in 
anti-inflammation. However, Zhang et al. (1997) reported a contradictory 
finding that SLPI failed to modulate TNF-a production by human monocytes 
although it suppressed the production of prostaglandin H synthase-2, 
prostaglandin E2, and matrix metalloproteinases. Therefore, the effects of 
serine protease inhibitors on production of TNF-a in macrophage are still 
controversial. 
2.2 Rationale of the present study 
Immunomodulation can be defined as any type of therapeutic intervention 
aimed to restore the normal function of the immune system. 
Immunomodulators are drugs that can directly modify a specific immune 
. function; it can have a net positive effect (immunostimulation) or a net 
negative effect (immunosuppression). The clinical use of immunomodulators 
includes the reconstitution of immune deficiency and the suppression of 
normal or excessive immune functions in the treatment of graft rejection or 
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autoimmune diseases (Schorlemmer et al； 1999; Osservoort et al.’ 1998). It 
is of worldwide interest to search for potential drugs with 
immunomodulatory effects (Labadie et al., 1988; Chihara, 1992). The seeds 
of Momordica cochinchinensis is known to be anti-inflammatory (Cheung 
and Li, 1985). Since there is a close relationship between protease inhibitors 
and the immune system, it would be of interest to see whether the 
chymotrypsin-specific inhibitor MCCI, isolated from Momordica 
cochinchinensis, has any effect on the different types of cells in the immune 
system. 
2. 3 Materials and methods 
2.3.1 Materials 
‘ BALB/c mice (6-week old) and blood sample were obtained from the 
‘ Laboratory Animal Services Centre at the Chinese University of Hong Kong. 
L-Glutamine, fetal calf serum (FCS) and all other cell culture materials were 
purchased from Gibco BRL. RPMI1640 medium, penicillin, streptomycin 
. sulfate was purchased from Invitrogen. MTT, ConA, LPS, ATP, SBTI, 
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sulfate was purchased from Invitrogen. MTT, ConA, LPS, ATP, SBTI, 
horseradish peroxidase and all other chemicals were purchased from Sigma 
Chemical Company. ^H-TdR was purchased from Amersham Bioscience. 
Hisafe 2 liquid scintillation cocktail was purchased from Perlineler. 
Hydrochloric acid and TCA were of the highest grade from Merck. BBS and 
HBSS were freshly prepared before use. PBS was prepared by dissolving 136 
mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4 and 8 mM NazPCU in distilled 
water. The pH of PBS was adjusted to 7.4. All apparatuses and solutions for 
cell culture were sterilized by high temperature and filtration respectively. 
2.3.2 Isolation of different types of immune cells 
2.3.2.1 Isolation of splenocytes 
Spleen cells were prepared from the spleens of BALB/c mice. After the mice 
‘ were sacrificed by cervical dislocation, the spleens were removed aseptically. 
‘ They were then cut into small pieces and pressed gently through a 200-gauge 
stainless steel sieve using a plunger of 5 ml sterile plastic syringe. After 
washing with RPMI medium, low-speed centrifugation (100 x g for 30 sec) 
was carried out to remove adipose tissue and connective tissue. The cell 
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observable white debris embedded in the cell pellet was removed. The 
resulting cell pellet was resuspended in RPMI medium supplemented with 10 
o/o FCS. 
2.3.2.2 Isolation of splenic lymphocytes 
The suspension of splenocytes was slowly layered onto the surface of an 
equal volume of Ficoll-paque gradient. The mixture was then centrifuged at 
800x g for 20 min at 20 Viable lymphocytes were collected at the 
interface between the two layers. The cells were then washed twice with 
plain RPMI medium and resuspended in RPMI complete medium. 
, 2.3.2.3 Isolation of bone marrow cells 
The femurs of BALB/c mice were removed and put into a Petri dish 
containing cold RPMI complete medium. The marrow plugs were flushed 
with RPMI complete medium using a 2 ml syringe with a 25 G needle. The 
cells were spun down at 400 x g for 5 min and red cells were removed by 
Ficoll-paque gradient centrifugation. The bone marrow cells were washed 
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twice with plain RPMI medium and resuspended in complete RPMI medium. 
2.3.2.4 Isolation of neutrophils 
Pellet cells from the plasma were prepared by centrifugation at 250 g for 10 
min at 4 °C. The pellet cells were washed twice and resuspended in a balance 
salt solution (BBS) containing 137 mM NaCl, 5mM KCl, 8.5 mM Na2HP04, 
0.8 mM MgS04,5 mM glucose, pH 7.4. About one-fifth volume of the cell 
suspension of Ficoll-paque solution was introduced beneath the cell 
suspension using a pipette. After centrifugation at 1400 rpm for 40 min, the 
top layer in the centrifugation tube was aspirated, leaving the neutrophils/red 
blood cell pellet. To remove residual red blood cells, cells were subjected to 
hypotonic lysis by resuspending each neutrophil/red blood pellet in 20 ml 
cold 0.2% NaCl for 30 sec. Then cells were resuspended and centrifuged 
, twice until the cell pellet appeared to be free of red blood cells. 
2.3.2.5 Isolation of macrophages 
BALB/c mice (6-week old) were obtained from the Laboratory Animal 
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Services Centre at the Chinese University of Hong Kong. Three days after 
thioglycollate (TG) injections, macrophages were obtained by peritoneal 
lavage with Hanks' balanced salt solution containing 10 mM Hepes (pH 7.4) 
and 3.5 mM NaHCOs (HBSS). The cells were washed once with HBSS and 
suspended in RPMI-1640 medium containing 2 mM glutamine, 12.5 units/ml 
penicillin, 6.5 mg/ml streptomycin, and 5% fetal calf serum. The cells were 
plated at a cell density of 4.0 x 10^  cells/well into 96-well plate and incubated 
for 2 hr at 37°C in a humidified CO2 incubator. 
2.3.3 Determination of cell proliferation 
Cells were plated in flat-bottomed 96-well culture plates at a density o f 2 x 10^  
cells / well in RPMI-1640 medium. After incubation with various samples for 
a certain time period, the cells in each well were pulsed with 0.5 [lC\ ^H-TdR 
and then harvested 5 hr later. The radioactivity incorporated was determined 
/ 
by counting in a liquid scintillation counter. 
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2.3.4 Determination of H2O2 formation 
Cells (4 X 104) suspended in BBS containing phenol red (100 |ig/ml) and 
horseradish peroxidase (50 |ag/ml) were stimulated with LPS (25 nM) 
dissolved in medium (0.001% final concentration). Different concentrations 
of samples were then added. After the mixtures were incubated at 37 °C for 2 
hr, the amount of oxidized phenol red, which is a measure of H2O2 produced 
by cells, was determined by absorbance at 590 nm. 
2.3.5 Assay of interleukin-2 
Interleukin-2 activity was assayed by the ability of the culture medium to 
- maintain the lymphoproliferation of ConA blast (Gramatzki et al,, 1982). 
ConA blast was prepared from a 3 day culture of BALB/c splenocytes (10^) 
in 10 ml RPMI medium supplemented with 10 %FCS, 1 |ag/ml ConA in a 25 
cm2 culture flask. ConA blast thus obtained was freed from residual ConA by 
washing it twice with medium. Viable cells were suspended at 4 x 10^  
cells/ml. Meanwhile, 2-fold serial dilutions of the culture medium from the 
wells with samples were prepared in a 96-well flat-bottomed microtiter plates 
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with a final volume of 50 |il each. Fifty microliters of the suspension of blast 
cells (4x lOV ml) were then added to each well and the plate was incubated 
for 16-24 hr at 37 °C in a humidified atomsphere containing 5 % CO2 in air. 
The cells in each well were pulsed with 0.5 |aCi ^H-TdR and then harvested 5 
hr later. The radioactivity incorporated was determined by counting in a 
liquid scintillation counter. 
2.3.6 Determination of cell viability 
A stock solution ofMTT (5 mg/ml) was prepared in PBS and filtered through 
a 0.2 \im filter to remove undissolved MTT powder. The MTT stock solution 
was diluted to 0.5 mg/ml with serum-free RPMI 1640 medium. Cells were 
seeded onto a 96-well plate. After MCCI and/or other samples, cells were 
washed with PBS twice and 400|il of diluted MTT solution were added to 
each well. The formazan crystals formed in active metabolic cells were 
extracted with 400 10% SDS in 1 OmM HCl after 2hr of incubation at 37°C. 
The absorbance was determined at 540 nm. SDS solution was used as blank. 
Cell viability was calculated as follow: 
62 
f 
o/o viability = [(OD540 treated group — blank)/(OD540 control - blank)] x 100 % 
2.4 Results 
2.4.1 Murine splenocytes 
2.4.1.1 In vitro effect of MCCI on the proliferation of murine splenocytes 
MCCI could slightly stimulate the growth of splenocytes by about 50 % at a 
concentration of 100 |ig/ml. On the other hand, ConA, a well-known mitogen 
for splenocytes, enhanced the growth of splenocytes by 2.5 fold at a 
concentration of 25 ng/ml. The effect plateaued at higher ConA 
concentration. MCCI showed a co-mitogenic effect with ConA as the 
resultant percentage of growth stimulation was about the same as the sum of 
those for ConA and MCCI alone (Figure 2.1). 
2.4.1.2 Effect of MCCI on cytokine production 
As shown in Figure .2.2，MCCI increased the production of IL-2 in 
splenocytes. The effect was more potent than that of ConA. At a 
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Figure 2.1 Effect of MCCI and ConA on the proliferation of 
splenocytes. BALB/c splenocytes (2 x 10^  cells/well) were incubated with 
various concentrations of MCCI ( • ) , ConA ( • ), or MCCI + ConA ( • ) 
at 37 °C for 48 hours. Culture were then pulsed with 0.5 i^Ci of^H-TdR for 8 
hr before harvest. Radioactivity in counts per minute (cpm) was measured 
using a liquid scintillation counter. Each value represents mean 士 standard 
error from two separate experiments, each performed in triplicate. 
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Figure 2.2 Effect of MCCI and ConA on IL-2 production in 
splenocytes. The effect of MCCI ( • ), ConA ( • )，and MCCI + ConA ( • ) 
were compared. IL2 was quantified by the method described in Section 2.3.5. 
Each value represents mean 土 standard error from two separate experiments, 
each performed in triplicate. 
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for MCCI and ConA respectively. The increase leveled off at higher 
concentrations. 
2.4.2 Murine lymphocytes 
2.4.2.1 In vitro effect of MCCI on the proliferation of lymphocytes 
As shown in Figure 2.3, MCCI exerted a positive effect on the proliferation 
of lymphocytes. The maximal stimulation of lymphocytes growth by MCCI 
was comparable to that caused by ConA, although the potency was lower. 
For ConA, maximal stimulation on the growth was observed at 2 |ig/ml 
while 20 |ag/ml of MCCI was needed for maximal stimulation. Beyond the 
optimal concentration, the effect of growth stimulation for both MCCI and 
ConA gradually diminished and restored to the control level. 
2.4.2.2 Effect of MCCI on cytokine production 
Similar to the effect on. splenocytes, MCCI also caused an increase in IL-2 
production. The production of IL-2 in lymphocytes (4 fold, Figure 2.4) was 
more than that of splenocytes (3 fold, Figure 2.2) after treatment with 10 
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Figure 2.3 Effect of MCCI and ConA on the proliferation of 
lymphocyte. BALB/c lymphocytes (2 x 10^  cells/well) were incubated with 
various concentrations of MCCI ( • ) or ConA ( • ) at 3 7 � C for 48 hours. 
Culture were then pulsed with 0.5 \iCi of 3H-TdR for 8 hr before harvest. 
Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Each value represents mean 土 standard error from two 
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Figure 2.4 Effect of MCCI and ConA on IL-2 production in 
lymphocytes. The effect of MCCI ( • ) , ConA ( • )，and MCCI + ConA ( • ) 
were compared. IL2 was quantified by the method described in Section 2.3.5. 
Each value represents mean 土 standard error from two separate experiments, 
each performed in triplicate. 
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|Lig/ml MCCI administration. The combined effect of MCCI and ConA was 
more potent than that of MCCI or ConA alone, especially at low sample 
concentrations, for example, below 1 |ig/ml. 
2.4.3 Murine bone marrow cells 
2.4.3.1 Effect of MCCI on the growth of murine bone marrow cell 
MCCI exhibited a significant stimulatory effect on the proliferation of 
murine bone marrow cells. Maximal stimulation was seen at a concentration 
of 2'|Lig/ml MCCI administration. The effect declined with further increase in 
MCCI concentration. MCCI was comparable to ConA in both the maximal 
growth stimulation effect as well as the potency (Figure 2.5). 
2.4.4 Murine neutrophils 
2.4.4.1 Effect of MCCI on H^Oiformation 
MCCI exerted about 80 % inhibition on H2O2 formation after activation of 
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Figure 2.5 Effect of MCCI and ConA on the proliferation of bone 
marrow cells. BALB/c bone marrow cells (2 x 10^  cells/well) were 
incubated with various concentrations of MCCI ( • ) or ConA(•) at 3 7 � C 
for 48 hr. Cultures were then pulsed with 0.5 |LiCi of ^H-TdR for 8 hr before 
harvest. Radioactivity in counts per min (cpm) was measured using a liquid 
scintillation counter. Each value represents mean 土 standard error from two 
separate experiments, each performed in triplicate. 
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protease inhibitors. For example, aprotinin and soybean trypsin inhibitor 
(SBTI) only caused a maximal inhibition of 30 % and 20 % respectively 
(Figure 2.6). 
2.4.5 Murine macrophages 
2.4.5.1 Effect of MCCI on the growth of macrophages 
MCCI could increase the growth of macrophages by about 40% at a 
concentration of 50 i^g/ml (Figure 2.7). The effect plateaued at 12.5 |Lig/ml of 
MCCI and the maximal stimulatory effect on the growth of macrophage was 
found after 48 hr of incubation with MCCI (Figure 2.8). The effect gradually 
decreased with longer incubation time. 
2.4.5.2 Effect of external ATP on the growth of macrophages 
Within the range of ATP administration from 0.625 mM to 10 mM, there was 
a dose-dependent growth suppression of macrophages. The growth inhibition 
was about 50 % at 10 mM ATP (Figure 2.9). 
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Figure 2.6 Effect of protease inhibitors on the inhibition of H2O2 
production in neutrophils. Cell suspensions of neutrophils (4 x 10'^ ) were 
seeded to 96 well plate and was pre-incubated with lOfig/ml LPS for 6 hr. 
After the pre-incubation, cells were washed twice with PBS. Different 
concentrations of different protease inhibitors, MCCI (•)，aprotinin (a 
trypsin inhibitor) ( • ) and soybean trypsin inhibitor SBTI ( • ) were 
administrated to the cells incubated with 25 nM phenol red and 50 )^g/ml 
horseradish peroxidase at 37 °C for 2 hr. The absorbance was determined at 
590 nm. Each value represents mean 土 standard error from two separate 
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Figure 2.7 Effect of MCCI on the growth of macrophages. Mouse 
resident peritoneal macrophages (4 x lO*) were seeded to 96-well plate and 
was incubated for 48 hr with different concentrations of MCCI. After the 
incubation period, cells viability was evaluated by MTT assay. Each value 
represents mean 土 standard error from two separate experiments, each 
performed in duplicate. 
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Figure 2.8 Time course of the effect of MCCI on the growth of 
macrophages. Mouse resident peritoneal macrophages (4 x 10"^ ) were seeded 
to 96-well plate and was incubated with 100 |ig/ml MCCI solution (in PBS) 
for different time periods. Cells viability was measured by MTT assay. Each 
value represents mean 土 standard error from two separate experiments, each 
performed in duplicate. 
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Figure 2.9 Effect of external ATP on the growth of macrophages. Mouse 
resident peritoneal macrophages (4 x lO*) were seeded to 96-well plate and 
incubated for 48 hr with different concentrations of ATP. After the incubation 
period, cell viability was evaluated by MTT assay. Each value represents 




2.4.5.3 Effect of ATP on the growth of macrophages pre-treated with MCCI 
After treatment with 100 [ig/m\ MCCI alone, there was 50 % increase in 
growth of macrophages. After further incubation with 0.625 mM to 10 mM 
ATP for 48 hr, the growth was suppressed by 55-75 %. The reduction in 
percentage in the growth of macrophage by 10 mM ATP after pre-incubation 
with MCCI (Figure 2.10) (about 75%) was greater than that (50%) of 10 mM 
ATP alone in the previous experiment (Figure 2.9). 
2.4.5.4 Effect of MCCI on the growth of macrophage pre-treated with ATP 
After treatment with 10 mM ATP alone, there was 50 % decrease in the 
growth of macrophage. After further incubation with MCCI (20 to 100 |ig/ml) 
for 48 hr, the growth was enhanced by 200 to 400 % (Figure 2.11). It was 
noted that increase (about 400 %) in the growth of macrophage by 100 ^ig/ml 
MCCI in this pre-incubation experiment was much greater than that (50%) of 
100 |ig/ml MCCI alone in the previous experiments (Figure 2.10) 
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Figure 2.10 Effect of external ATP on the growth of macrophages after 
pre-incubation with MCCI. Mouse resident peritoneal macrophages (4 x 
104) were seeded to 96 well plate and was pre-incubated with 100 ^ig/ml 
MCCI solution (in medium) for 24 hr. After the pre-incubation, cells were 
washed twice with PBS. Different concentrations of ATP in RPMI 1640 were 
administrated and cells were incubated at 37 °C, 5% CO2 for 48 hr. Cell 
viability were determined by MTT assay. Each value represents mean 土 
“ standard error from two separate experiments, each performed in duplicate. 
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Figure 2.11 Effect of MCCI on macrophages after pre-incubation with 
ATP. Mouse resident peritoneal macrophages (4 x 10'^ ) were seeded to 96 
well plate and pre-incubated with 10 mM ATP for 24 hr. After the 
pre-incubation, cells were washed twice with PBS. Different concentrations 
of MCCI in RPMI 1640 were administrated to cells and incubated at 37 °C, 
5% CO2 for 48 hr and cell viability were determined by MTT assay. Each 
value represents mean 土 standard error from two separate experiments, each 
- performed in duplicate. 
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2.4.5.5 Effect of MCCI on H?09 production 
Similar to the case of neutrophils (Figure 2.6)，MCCI inhibited LPS-induced 
H2O2 production in macrophages in a dose-dependent manner. It showed 
about 55% inhibition on H2O2 production at 100 \xg/m\ MCCI (Figure 2.12). 
The suppression effect of MCCI was strongest with an incubation time 
between 3 and 4 hr (Figure 2.13). • 
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Figure 2.12 Effect of MCCI on the inhibition of H2O2 production in 
macrophages. Mouse resident peritoneal macrophages (4 x 1O^ ) were seeded 
to 96-well plate and were pre-incubated with 10|ag/ml LPS for 6 hr. 
Following the pre-incubation, cells were washed twice with PBS. Different 
concentrations of MCCI solution (in PBS) were administrated to the cells and 
incubated with phenol red and horseradish peroxidase at 37 °C for 2 hr. The 
- absorbance was determined at 590 nm. Each value represents mean 土 
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Figure 2.13 Time course of MCCI on the inhibition of H2O2 
production. Mouse resident peritoneal macrophages (4 x 10"^ ) were 
seeded to 96 well plate and was pre-incubated with 10 |j,g/ml of LPS for 6 
hr. Following the pre-incubation, 100 |ag/ml MCCI solution (in PBS) was 
administrated. Cells were then incubated with phenol red and horseradish 
peroxidase at 37 °C, 5% CO2 for different time periods. Absorbance was 
determined at 590 nm. Each value represents mean 土 standard error 
“ from two separate experiments, each performed in duplicate. 
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2.5 Discussion 
In the search for new immunomodulatory agents over the past few years, 
many traditional herbal medicines have been evaluated. Traditional 
medicinal herbs that are used as tonic are thought to nourish and strengthen 
the host defense mechanisms. There are many reports showing that 
traditional medicinal herb extracts can enhance various types of immune 
responses (Hu et al., 2003; Zhao et al, 1990). However, it is not clear 
how the crude extracts work on the immunological system, particularly on 
the physiological effect of the individual component in the extract. 
Momordica cochinchinensis, belonging to the Cucurbitaceae family, as a 
crude extract, is used for its anti-inflammatory effects in traditional medicine 
(Cheung and Li, 1985). It has been reported that the seeds of Momordica 
cochinchinensis are rich in serine protease inhibitors. The abundance of the 
chymotrypsin-specific inhibitor is relatively high compared with other plants 
in the same family (Wong, 2001). Knowing that the interaction between 
proteases and protease inhibitors is of significant importance in the proper 
functioning of the immune system (Nagai et al., 1978; Flannelly et al., 
• 82 
f 
2002), it is of interest to determine whether the chymotrypsin-specific 
inhibitor MCCI is responsible for, at least, part of the anti-inflammatory 
effects of Momordica cochinchinensis. 
Splenocvtes 
MCCI exerted a mitogenic effect on the proliferation of splenocytes. The 
potency was relatively weak when compared with the trypsin-chymotrypsin 
inhibitor isolated from broad bean by Ye et al (2001). Mitogenic activity on 
splenocytes is generally accompanied by the induction of cytokines e.g. IL 2 
(Takeyoshi et al.，1998). About 3-fold increase in the production of IL 2 was 
observed at 10 |ag/ml MCCI. It has to be noted that the growth of splenocytes 
was not entirely due to the effect of IL 2 as the increase in the growth of 
splenocytes by MCCI was much lower than that of ConA though the increase 
in the production of IL 2 by MCCI was higher. 
Lymphocytes 
Both MCCI and ConA exhibited a biphasic effect on the growth of 
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lymphocytes. The dose-response curve (Figure 2.3) showed that while the 
maximal stimulation was similar in both cases, MCCI was less potent and a 
higher concentration was needed to obtain maximal stimulation. Little data 
are available about the effect of protease inhibitors on lymphocyte 
proliferation and cytokine production. The only information is on the 
modification of angiotensin-converting enzyme activity (Lijnen et al, 
1999). IL 2 is one of the cytokines for lymphocyte activation (Mazzone et aL, 
1999). The present results showed that MCCI could stimulate the production 
of IL 2 in lymphocytes, similar to that in splenocytes, in a dose-dependent 
manner (Figure 2.4). Indeed, the fold of increase of IL 2 was higher in 
lymphocytes than in splenocytes. Thus, MCCI was believed to play a role in 
the signaling pathway. 
Bone marrow cells 
MCCI could stimulate the proliferation of bone marrow cells and the pattern 
of stimulation was similar to that in lymphocytes i.e., the growth percentage 
increased at low concentrations of MCCI while the stimulating effect would 
gradually disappear at higher MCCI concentrations (Figure 2.5). To the best 
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of my knowledge, there are no reports on the effect of serine protease 
inhibitors on bone marrow cells. On the other hand, there is limited 
information on other types of proteases in bone marrow cells. For example, 
osteoclasts are known to secrete large amount of cysteine proteases, 
especially procathepsin L, which powerfully degrades type-1 collagen, 
leading to tumor-associated bone absorption and release of bone calcium. 
Specific cysteine protease inhibitors could prevent bone metastasis (Nikava 
et al., 2002). Different metalloproteinases MMP2, MMP3, MMP7 and 
MMP9 were found in murine cartilages and the tissue metalloproteinase 
inhibitors were found to be able to prevent the degradation of cartilage 
(Flannelly et al, 2002). 
Neutrophils 
The activation of neutrophils is accompanied by the production of hydrogen 
peroxide which may have an adverse effect on cells. MCCI was found to 
inhibit the production of H2O2 in neutrophils. Its action was more potent than 
that of aprotinin and soybean trypsin inhibitor (SBTI), consistent with the 
findings of Kitagawa et al (1979) that some chymotrypsin-specific inhibitors 
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purified from legumes were more effective than trypsin inhibitors inhibiting 
H2O2 production in neutrophils. In the intracellular granules of mature 
neutrophils, there are different kinds of enzymes, e.g. myeloperoxidases, acid 
hydrolases, lysozyme as well as some proteases which have not been well 
characterized. The secretion of these enzymes results in an activation of 
neutrophils (Belleau et al., 1989). It is supposed that there are also 
chymotrypsin or chymotrypsin-like proteases in the granule of mature 
neutrophils (Kitagawa et al., 1979). The interaction between the proteases 
and the protease inhibitors may result in a fine modulation of the 
physiological functions of neutrophils, probably its cytotoxic function against 
external invasion. 
Macrophages 
MCCI could increase the proliferation of macrophage by about 50% at the 
concentration of 100 |ag/ml and the maximal effect was found with an 
incubation time period of 48 hr (Figures 2.7 and 2.8). Such results agreed 
with those of Abate and Schroder (1998) who found that the serine protease 
inhibitors TPCK and TLCK could protect against the growth suppression 
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effect induced by the cytotoxic effect of LPS in macrophages. An early phase 
of the signaling pathway for macrophage proliferation involves the 
translocation of nuclear transcriptional factor (NF-KB) into the nucleus. This 
process can be prevented by inhibiting proteases which activate IKB a for the 
transport of NF-KB. Thus, it is reasonable for MCCI, a serine protease 
inhibitor, may inhibit this process with the same mechanism. This was 
supported by the findings of Zhu et al (1999) that the response to LPS was 
blocked by the transfection of SLPI in macrophages. The breakdown of 
IKBOC showed a time-dependent pattern with the 24 hr incubation period, 
however, the effect at longer incubation time has not been examined (Zhu et 
al, 1999). 
Adenine triphosphate (ATP) is a well-known stimulus for macrophages in 
inducing respiratory burst. Extracellular ATP itself elicits the generation of 
superoxide (0.2) in peritoneal macrophages in association with an increase in 
cytosolic calcium level (Nicosia et al., 1990). The effective dosage was 
within 0.1-1 mM ATP and no investigation has been performed with higher 
ATP concentrations in macrophage. In the present study, up to 10 mM ATP 
was added to the culture of macrophages. After incubation with 10 mM ATP 
‘ 87 
for 48 hr, 50 % cell death was observed (Figure 2.9). Such cell killing effect 
could probably be due to the attack by the large amount of reactive oxygen 
species released in the activation of macrophages. 
In order to have a clear picture about the interaction between MCCI, ATP 
and macrophages, pre-incubation experiments with different samples were 
carried out. One was pre-incubation of MCCI for 24 hr followed by the 
addition of ATP and the other involved the pre-incubation of ATP for 24 hr, 
followed by MCCI. After the pre-incubation of one sample, the cells were 
washed with PBS twice to ensure that no traces of the first sample was left in 
the extracellular space of macrophages before addition of the second sample. 
For the pre-incubation with MCCI followed by addition of different 
concentrations of ATP, the growth stimulation effect of MCCI was inhibited 
by ATP in a dose-dependent manner (Figure 2.10). MCCI (100 jig/ml) alone 
could increase the growth of macrophages by about 50 %, but the growth 
percentage decreased after the second incubation with 0.625 mM ATP for 48 
hr. In the case of ATP pre-incubation, the suppressive effect of ATP was also 
reversed by MCCI in a dose-dependent manner (Figure 2.11). Ten millimolar 
ATP alone suppressed the growth rate by 50 % while there was an increase in 
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the growth of macrophages upon further incubation with 100 fig/ml MCCI. 
Combining the results of the two experiments, the effect of MCCI was more 
significant after preincubation with ATP, and vice versa. Thus, it appears that 
the pre-incubation with MCCI activates the signaling pathway for the action 
of ATP and the pre-incubation of ATP might activate the action of MCCI. It 
remains unknown how MCCI triggers the cell signaling pathway. Another 
protease inhibitor, a-macroglobulin, is known to bind to the surface receptor 
of macrophages. The interacting sites for a-macroglobulin on the membrane 
of macrophages have been well characterized with respect to its structure and 
response to ligands (Wu and Pizzo, 1996). They are coupled with G-protein 
and cause the induction of cyclooxygenase-2 for phagocytosis. The 
modulation of phagocytosis could be accompanied with interaction between 
the proteases inside the cells and its cognate inhibitor. MCCI seems to be 
involved in removing the reactive species in cells. It was supported by the 
fact that MCCI inhibited H2O2 production in macrophages in a time- and 
dose-dependent manner (Figures 2.12 and 2.13) though the effectiveness was 
lower than that in neutrophils. 
To sum up, MCCI showed an immunostimulatory effect on the growth of 
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three types of important immune cells, splenocytes, lymphocytes and bone 
marrow cells. In addition, it was involved in the differentiation of 
splenocytes and lymphocytes as indicated by the increase in the expression of 
IL 2. Such differentiation is an important process for cell maturation to carry 
out its physiological role against different immune responses. 
MCCI also exhibited anti-inflammatory activity. It inhibited the production 
of H2O2, an important feature of anti-inflammation, in both neutrophils and 
macrophages. Neutrophils generally adhere to the vascular endothelium and 
migrate to the site of infection, which leads to ingestion and killing of the 
pathogen while macrophages also play critical accessory, inflammatory, and 
effector roles in the non-septic T cell-mediated inflammatory response 
(Martin et al, 1992; Gerritse et al., 1996; Huitanga et al., 1995). The 
neutrophils and macrophages are the two common cell models for the 
investigation of anti-inflammatory agents. MCCI reverted the cytotoxic 
effect of ATP, as shown by the observation of the increase in the growth of 
macrophages after pre-incubation with ATP. This may also be due to the 
reduction in the toxic reactive oxygen species, H2O2, which is the main side 
product in the activation of macrophages (Kaul et al, 1998). 
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Chapter 3 Anti-oxidative effect of MCCI in a 
primary rat hepatocyte culture 
3.1 Introduction 
3.1.1 Liver disease and protease inhibitors 
The control of hemorrhage during liver resection remains a major technical 
issue associated with perioperative mortality and morbidity (Nagorney et al, 
1989; Matsumata et al, 1990). Although hemorrhage can be prevented by 
total clamping of the hepatic pedicle, the procedure can induce profound 
hepatic ischemia/reperfusion (I/R) injury that is potentially life threatening, 
particularly in the compromised liver (Delva et al” 1990). The 
pathophysiology of I/R injury to the liver has been investigated with a view 
to its prevention, and oxygen-derived free radicals, neutrophils, and 
inflammatory cytokines have been implicated as components (Grace, 1994; 
Bulkley et al, 1994). Several in vivo and in vitro experiments have 
demonstrated that protease inhibitors have a hepatoprotective effect against 
I/R injury, in association with suppression of the factors mentioned (Kim et 
al； 2002; Horiuchi et al, 2001). In this prospective, a study of gabexate 
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mesilate (GM), a synthetic protease inhibitor, on the effect of I/R injury in 
a clinical setting has been carried out and finally the preoperative 
administration of GM was found to be useful in preventing I/R injury of 
human liver, accompanied by suppression of the plasma pro-inflammatory 
cytokines (Kim et al, 2002). As there is a close relationship between 
protease inhibitors and the liver, the exploration of the clinical application of 
protease inhibitors should be advocated. 
In addition to I/R, protease inhibitors may also be useful for treating 
alcoholic liver disease (ALD). Ethanol metabolism in liver causes an increase 
in the level of reactive oxygen species (ROS) which in turn results in cell 
damage and lipid peroxidation (Heaton et al, 2003; Kukielka et al” 1994). 
- Lipid peroxidation is one of the main reasons for liver injury. The initiation 
of lipid peroxidation is mainly triggered off by two routes: interaction with 
free radicals (Gogvadze/ et al” 2003; Casalino et al” 1996) and activation of 
neutrophils (Halliwell and Chirico, 1993). The former is a well-established 
cause for hepatic lipid peroxidation while the latter has not been examined 
extensively. The initiation of lipid peroxidation by the activation of 
neutrophils was usually investigated in ulcerated gastric tissues (Kobayashi 
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et al, 2002). Surprisingly, urinastatin, a protease inhibitor, has been found to 
be effective against hepatic lipid peroxidation by inhibiting enzymes from 
activated neutrophils e.g. collagenase, elastase and gelatinase (Htwe et al, 
1996). Thus, further investigations are worthwhile to examinae the effect of 
protease inhibitors on hepatic lipid peroxidation, and see whether protease 
inhibitors are useful in treating liver diseases. 
3.1.2 Primary rat hepatocyte as a pharmacological model 
Isolated rat hepatocyte culture is widely used as a model in toxicological and 
pharmacological studies. Primary rat hepatocyte culture retains many 
physiological characteristics of the intact liver such as a relatively high level 
•‘ of cytochrome P450 content. The antioxidant status of isolated hepatocytes is 
similar to that of intact liver (Richert et al, 2002). Hepatocytes can be 
readily isolated and simple culture conditions are sufficient to support normal 
cell metabolism. Rodent hepatocyte culture, in addition to animal models, 
has been used for investigating liver regeneration, proliferation and 
differentiation (Conpagnon et al, 2002). The monolayer hepatocyte culture 
provides a simplified system for studying xenobiotic metabolism, hormonal 
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action, and bile secretion (Boyer et al., 1988). Though the environment 
surrounding hepatocytes is well defined as a result of a long history of 
pharmacological investigation, it was only adopted recently for investigating 
the hepatic effect of protease inhibitors (Kim et al, 2002). 
3.1.3 tert-Buty\ hydroperoxide as an oxidative stress inducer 
tert-Buty\ hydroperoxide (1,1 -dimethylethylhydroperoxide; /BHP) is an 
organic peroxide used for catalyzing polymerization reactions in industries. It 
introduces proxy groups into molecule and produces free radicals in the 
substitution of nitriles (Kharasch and Sosnovsky, 1958). These reactions are 
catalyzed by transition metal ion. tBU? reacts with transition metal ions, 
- such as copper (II) ion, to give tert-buioxy\ radical. This radical attacks other 
molecules with subsequent self-reduction to form tert-huty\ alcohol (^BAL). 
rBHP is also commonly used as an oxidative stress inducer in toxicological 
and pharmacological experiments. It can be metabolized by erythrocytes and 
hepatocytes. It is most commonly converted to rBAL by glutathione 
peroxidase (GPx) with the consumption of GSH in isolated rat hepatocyte (di 
Simplicio and Rossi, 1994). Metabolism of ^BHP thus leads to rapid 
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depletion of the intracellular GSH pool. Previous studies have found that 
exposure of rat hepatocytes to /BHP results in lipid peroxidation (Dogterom 
et al, 1998), GSH oxidation, mitochondrial damage (Massa and Giuliui, 
1993), disruption of Ca^^ homeostasis (Sweetman et al., 1995) and inhibition 
of protein synthesis (Fraga et al, 1989). /BHP is also metabolized by the 
microsomal cytochrome P450 dependent system to form free radical 
intermediates (Minotti et al, 1986). It reacts with mitochondrial cytochrome 
c and cl and results in the generation of methyl, tert-butoxy\ and 
,er,-butylperoxyl radicals (Thompson et al., 1995). 
The model of inducing oxidative stress in hepatocytes with rBHP is 
commonly used to investigate the antioxidant activity of various compounds 
- or herbal extracts (Gebhardt, 1997; Dubuisson et al., 2000; Kmonickova et 
al” 2001; Yau et al, 2002). Antioxidant compounds such as vitamin E 
protect isolated hepatocytes against rBHP induced oxidative damage. Some 
protease inhibitors, especially the chymotrypsin-specific type, were found to 
be involved in anti-inflammation (Tamura et al, 1992). The effect of serine 
protease inhibitors on the regulation of inflammation in the rat pineal gland 
(Takamiya et al, 2002) and skin (Udaka and Hayashi, 1965) have been 
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investigated. Compounds that can increase intracellular antioxidant enzyme 
activity and expression can be considered as antioxidants as well as those 
which scavenge free radicals directly with their functional groups. In this 
regard, information on the potential enhancement of the antioxidant enzymes 
activities by protease inhibitors have been lacking. 
3.1.4 Endogenous antioxidant enzymes against ROS 
Four main intracellular antioxidant enzymes, namely, catalase, superoxide 
dismutase (SOD), glutathione-S-transferase (GST) and glutathione reductase 
(GR), are commonly examined in pharmacological investigation for 
interaction with ROS. 
3.1.4.1 Catalase 
Catalase (EC 1.11.1.6) catalyzes the detoxification of H2O2 to form water and 
molecular oxygen with reducing potentials (Reaction 3.1). Catalase is a 
tetrameric enzyme with four identical 60kDa subunits arranged tetrahedrally 
(Hamrris and Holzenburg, 1989). Each of them contains a 
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ferriprotoporphyrin group. The subunits also contain a NADPH molecule 
(Kirkman et al, 1987). Catalase is mainly located at peroxisomes which also 
contain most of the enzymes capable of generating H2O2. The content of 
catalase is very high in liver and erythrocytes but lower in other tissues. 
Catalase 
2H2O2 > 2H2O + O2 (Reaction 3.1) 
3.1.4.2 Superoxide dismutase (SOD) 
SOD (EC 1.15.1.1) catalyzes the dismutation of superoxide anion, O "^, to 
relatively less toxic H2O2 and oxygen (Reaction 3.2). Such activity 
therefore represents a source of H2O2 in cells. The H2O2 formed is then 
removed by catalase and GPx reactions. The activity of SOD depends on 
transition metal ions, for example, Zn, Mn and Cu. Two SOD isoenzymes are 
found in eukaryotic cells. The 32kDa dimeric Cu/Zn form is found in cytosol 
and the 80kDa tetrameric Zn-SOD is present in mitochondria. The 
Cu/Zn-SOD destroys superoxide by successive oxidation and reduction of 
the transition metal ion located at the active site through a 'ping-pong' type 
of reaction. Mitochondrial Zn-SOD contains one zinc (III) ion per subunit, 
which is reduced to zinc (II) after dismutating superoxide anion and 
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subsequently re-oxidized to zinc (III) ion. Mitochondrion is the major site 
of oxidative phosphorylation in which a large amount of superoxide is 
formed due to the leakage of electrons from the respiratory chain. The 
extremely efficient activity of SOD thus plays an essential role in protecting 
the integrity of mitochondria. 
SOD 
202- +2H+ > H2O2 + O2 (Reaction 3.2) • 
^,1.4.3 Glutathione-S-transferase (GST) 
GST (EC 2.5.1.18) is a phase II detoxification enzyme. Phase II enzymes 
catalyze the conjugation of hydrophobic xenobiotics with endogenous 
water-soluble substrates such as GSH (Jones, 2002), thus making lipophilic 
xenobiotics more water-soluble and less toxic, which facilitates their 
. elimination from cells. GST catalyzes detoxifying reactions involving GSH. 
It catalyzes thiol conjugation of aromatic substituents and peroxides, 
resulting in the formation of RSG (Reaction 3.3). This enzyme also removes 
ROS in cell and regenerates reduced thiol groups in oxidized proteins. GST 
is a dimeric enzyme mainly distributed in cytosol. A separate class of 
microsomal GST has distinct properties from the cytosolic form. Mammalian 
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GSTs are classified into the a, |i and p class, whose genes are distributed on 
different chromosomes . 
GST 
RX + GSH > HX + RSG (Reaction 3.3) 
3 • 1.4.4 Glutathione reductase (GR) 
GR (EC 1.6.4.2) does not interact with free radicals directly but provides 
support to the activity of GPx and GST by regenerating GSH with the 
oxidation ofNADPH (Reaction 3.4). This enzyme is essential in maintaining 
the glutathione level in cell. 
GR 
„ GSSG + 2NADPH > 2GSH + 2NADP+ (Reaction 3.4) 
3.2 Rationale of the present study 
The immunomodulatory effects of MCCI in different types of immune cells 
have been studied in Chapter 2. The applicability of protease inhibitors in 
hepatocytes is another important issue as protease inhibitors have been 
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suggested to be involved in anti-oxidation and anti-inflammation processes 
(Tamura et al, 1992). The underlying mechanisms are only partly 
explained. The mechanisms in the two processes may be similar to a certain 
extent, both involving ROS. Meanwhile, inhibition and scavenging of the 
ROS is an important topic in liver research which usually uses primary rat 
hepatocytes as the model system. On the other hand, Momordica 
cochinchinensis, containing different kinds of protease inhibitors, especially 
the chymotrypsin-inhibitor, is well known for its effect on liver function. The 
details of the pharmacological investigation are recorded. It was found to be 
effective in treating pyodermas, mastitis, tuberculous, cervical lymphadenitis, 
ringworm infections, freckles, sebaceous cysts, hemorrhoids and 
hemangiomas (Cheung and Li, 1985). All of these diseases involve 
inflammation and oxidative injury. Hence, it is worthwhile to test the 
antioxidant activity of MCCI in hepatocytes. In the present investigation, the 
cytotoxicity of MCCI will be studied in primary rat hepatocyte culture, 
followed by its effect on ^BHP induced oxidative stress Several oxidative 
- stress related parameters, namely GSH, GSSG，MDA and the activities of 
various antioxidant enzymes were investigated. 
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3.3. Materials and methods 
3.3.1 Materials 
Swim's S77 medium, William's medium E, Hank's balanced salt solution 
(HBSS), sodium phosphate, calcium chloride, EGTA, 
5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), Thiobarbituric acid (TBA), 
dexamethasone, insulin, pyruvate, NADH, MTT, SDS, GSH, type I collagen, 
type IV collagenase, Folin-Ciocalteu's phenol reagent and pentobarbital were 
purchased from Sigma. All other cell culture materials were purchased from 
Gibco BRL. Hydrochloric acid and TCA were of the highest grade from 
Merck. All apparatuses and solutions for cell culture were sterilized by high 
temperature and filtration respectively. 
3.3.2 Isolation of primary rat hepatocytes 
3.3.2.1 Liver perfusion 
Swim's S77 medium was used for liver perfusion. The medium was prepared 
according to instructions indicated in product menu and supplemented with 
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0.3 |liM insulin and BSA (1 mg/ml). This stock solution was further 
supplemented with 0.5 mM EGTA for the first-stage perfusion solution, 
while 9 mM CaCb and 0.4 mg/ml type IV collagenase were added to the 
second-stage perfusion solution. All perfusion solutions were pre-warmed to 
37°C and gassed with 95%02, 5%C02 before use. 
Male Sprague-Dawley rats weighing 200-250g as hepatocyte donors were 
obtained from the Laboratory Animal Services Centre at the Chinese 
University of Hong Kong. Rats were anesthetized by an intraperitoneal 
injection of pentobarbital (60 mg/ml, 1 ml/kg) and dissected immediately. 
Hepatocytes were isolated by two-stage collagenase perfusion as described 
by Seglen (1976). The liver was perfused with the first stage perfusion 
solution for lOmin at 20 ml/min followed by perfusion for another 10 min 
with the second stage solution at 10 ml/min via the hepatic portal vein. The 
liver was then excised and hepatocytes were released into William's medium 
E containing type IV collagenase (0.4 mg/ml). The hepatocytes were further 
incubated at 37°C for min with gentle shaking. Dead cells and debris were 
removed by Percoll centrifugation, which routinely yielded a cell 
preparation with viability higher than 90%. 
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3.3.2.2 Preparation of collagen pre-coated culture plates 
A lOx stock type VII collagen (from rat tail) was prepared in 5% acetic acid 
(in water; v/v) at 2mg/ml. Collagen stock was diluted to 0.2mg/ml with 
sterilized distilled water and added to culture plates according to the 
following table: 
Collagen, lal/well 
6-well culture plate 400 
24-well culture plate 100 
96-well culture plate 25 
100 mm dish 4000 
The plates were then allowed to dry at 37°C overnight or at room 
temperature for 48hr. The wells were washed with serum-free William's 
medium E to remove any acetic acid present prior to cell seeding. 
3.3.2.3 Hepatocytes culturing 
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Hepatocytes were seeded onto culture plates pre-coated with type I collagen 
at 2x10^ cells/well and 1x10^ cells/well for 24-well and 6-well plates 
respectively. For some experiments, hepatocytes were seeded onto 100 mm 
dishes at 1x10^ cells/dish. Cells were cultured in William's medium E 
supplemented with 0.3 \iM insulin, 0.1 |iM dexamethasone, 10% FBS and 
1% penicillin/streptomycin at 37°C, 90% humidity and 95% O2. All 
experiments were performed 24 hr after cell attachment to allow formation of 
a monolayer of cell. 
3.3c3 Drug treatment and oxidative stress induction 
MCCI solution was prepared in William's medium E and sterilized by 
^ filtering through a 0.2|im filter. Unless otherwise indicated, hepatocytes were 
pretreated with various concentrations of MCCI solution for 24 hr prior to 
exposure to oxidative stress. Hepatocytes were washed with HBSS to remove 
unabsorbed drug. Afterwards, cells were cultured with William's medium E 
containing 500 |iM 出HP for 3 hr to induce oxidative stress. For some 
experiments, hepatocytes were treated with MCCI extract and rBHP 
simultaneously. For the control group, the cells were not treated with any 
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rBHP nor MCCI solution. 
3.3.4 Cytotoxicity assessment 
The cytotoxicity assay was performed as described in Section 2.3.5. 
Hepatocytes were seeded onto a 24-well plate for cytotoxicity assessment. 
After MCCI and/or /BHP treatment, hepatocytes were washed with PBS 
twice and 400 i^l of a diluted MTT solution was added to each well and 
assayed accordingly. 
3.3.5 Cellular GSH content determination 
Cellular GSH content was determined by the DTNB spectrophotometeric 
method (Brehe and Burch, 1976). Hepatocytes seeded onto 6 well plates 
were washed with HBSS and trypsinized. Cells were then sonicated in 500 \i\ 
/ 
PBS for 10 sec on ice. Four hundred microlitres of the cell lysate were 
deproteinized by addii^g 100 |il 25% trichloroacetic acid and centrifuged at 
3,000 rpm for 10 min at 4°C. The supernatant was then added to the reaction 
mixture containing 0.12 mM DTNB in 0.1 M sodium phosphate, ImM EDTA, 
‘ 105 
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pH 8.0 and incubated for 15 min at room temperature. The colour 
generated was determined as absorbance at 412nm and GSH content was 
estimated with reference to the standard curve. GSH content was expressed 
in terms of nmoles/mg protein, with the protein concentration of the lysate 
determined with the method of Lowry et al, (1951). 
3.3.6 Protein determination by Lowry's method 
The protein concentration of the cell lysate was determined according to the 
method of Lowry et al. (1951). One hundred microlitres of the sample were 
added to 2 ml of 0.01% copper (II) sulfate, 0.01% potassium sodium tartrate, 
2% sodium bicarbonate in O.IM NaOH and allowed to stand for lOmin. 
„ Afterwards, 0.1 ml Folin-Ciocalteu's phenol reagent was added and the 
mixture was allowed to stand for another 90 min. Absorbance at 750 nm was 
determined and the protein concentration was estimated from the BSA 
standard curve. 
3.3.7 Medium MDA determination 
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For MDA determination, cells were treated with rBHP in HBSS instead of 
William's medium E, since the colour of William's medium E would 
influence the colorimetric determination of MDA. HBSS was collected after 
tBU? treatment. A 400-fil aliquot of HBSS was added to 400 of 
TBA-reagent containing 0.375% TBA, O.IM HCl, and 15% TCA (Wey et 
fl/.,1993). The mixture was heated at 100 °C for 30 min. After centrifugation 
to remove the precipitate, absorbance of the supernatant at 532 nm was 
determined. The MDA concentration was calculated from the MDA standard 
curve. 
3.3.8 Medium GSSG determination 
Hepatocytes were cultured in 6-well plates and treated with the MCCI 
solution for 24 hr prior to 广BHP challenge. The media were used for GSSG 
‘ determination. A 25-|il aliquot of the culture medium was added to 1ml 
‘ reaction mixture containing 5 mM EDTA, 15 |iM DTNB, lU glutathione 
reductase (from baker's yeast) and 50 (iM NADPH in O.IM sodium 
phosphate, pH 7.5 (Brehe and Burch, 1976). The mixture was incubated at 




3.3.9 Antioxidant enzyme measurement 
Hepatocytes were seeded onto 100mm culture dishes at 8x10^ cells/dish. The 
cells were treated with a MCCI solution (200 |ag/ml) for 24 hr. The 
hepatocytes were then washed with PBS twice, trypsinized and lysed by 
sonicating on ice. The lysate was centrifuged at 14,000 rpm for 30 min at 
4°C. Afterwards, the supernatant was saved for enzyme determination. 
3.3.9.1 Catalase measurement 
Catalase activity was determined according to the method of Aebi (1984). 
The decomposition of H2O2 was traced by measuring the decrease in 
absorbance at 240 nm. To a 450-|il aliquot of cell protein (1 mg/ml), 18 
50% absolute ethanol was added and incubated on ice for 30 min. Then 50 fil 
10% Triton X-100 (in 50 mM Tris-HCl, 0.1 mM EDTA, pH 7.6) was added. 
The change in absorbance at 240 nm of the reaction mixture containing the 
treated lysate, 10 mM H2O2 in 50 mM sodium phosphate, pH 7.0 was 
followed for 1 min. Catalase activity was expressed as |amole H2O2 
108 
decomposed/min/mg protein. The molar extinction coefficient of H2O2 is 
39.4 mlVrWi. 
3.3.9.2 SOD measurement 
SOD activity was determined according to the method of McCord and 
Fridovich (1969). The reaction mixture contained 10 [iM cytochrome c, 50 
|iM xanthine, 0.1 mM EDTA, 50 mM potassium phosphate, pH 7.8 and 6 
mU xanthine oxidase in the presence or absence of cell lysate. The reduction 
of cytochrome c by superoxide generated from xanthine was measured by the 
increase in absorbance at 550 nm. SOD inhibits the reduction of cytochrome 
c. The rate of cytochrome c reduction in the presence or absence of cell 
- lysate was determined. SOD activity was expressed as the amount of cell 
lysate, in |ig protein/ml, required to inhibit cytochrome c reduction by 50%. 
3.3.9.3 GST measurement 
GST activity was determined according to the method of Habig and Jakoby 
(1981). The enzyme activity was measured by following the change of 
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absorbance at 340 nm of the substrate, CDNB. The conjugation of CDNB 
causes a decrease in OD340 nm. The reaction took place in O.IM potassium 
phosphate buffer, pH 8.5 with 5mM GSH, ImM CDNB and 50 \xg/m\ cell 
lysate protein. GST activity was expressed as nmole CDNB conjugated 
with GSH/min/mg protein. The molar extinction coefficient of CDNB is 8.5 
3.3.9.4 GR measurement 
GR activity was determined according to the method of Carlberg and 
Mannervik (1985). The assay mixture contained ImM EDTA, 50 i^M 
NADPH, 1 mM GSSG and 50 |ag/ml cell lysate protein in O.IM potassium 
phosphate buffer, pH 7.0. The reduction of NADPH was followed by the 
decrease in absorbance at 340 nm. GR activity was expressed as nmole 
, NADPH oxidized/min/mg protein. The molar extinction coefficient of 
, NADPH is 6.22 mM-icm-i. 
I 
3.3.10 Statistical analysis 
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Data were analyzed by Student's t-test with one-way analysis. Significant 
difference was taken as p<0.05 and p<0.01 when compared with the 
corresponding control experiments or /BHP only. 
3.4 Results 
3.4.1 Cytotoxicity of MCCI on rat hepatocytes 
The possible toxicity of MCCI on rat hepatocytes was tested prior to the 
study of its antioxidant activity in cells. MCCI did not cause any observable 
toxicity when hepatocytes were treated at 50 |ig/ml and 100 i^g/ml with it for 
24 or 48 hr (Figure 3.1). When the dose was increased to 200 [ig/ml and 400 
|ig/ml, slight toxicity was observed. Nevertheless, over 80% of cell viability 
could still be retained. Thus, the maximum dose used in subsequent 
experiments was 100 |ig/ml. 
3.4.2 Effect of /BHP and MCCI on hepatocyte viability 
Treating hepatocytes with 500 |iM tBH? for 3hr caused cell damage as 
shown by the loss of cell viability (Figure 3.2). The addition of rBHP caused 
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Figure 3.1 Cytotoxicity test of MCCI on primary rat hepatocytes. 
Hepatocytes seeded onto 24 well plates (2x10^ cell/well) were treated with 
different concentrations of MCCI for either 24hr (grey bar) or 48hr (white 
bar). Cytotoxicity was estimated by MTT assay. Each value represents 
mean 士 standard error from 3 experiments, each performed in triplicate. 
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Figure 3.2 Effect of simultaneous treatment of hepatocytes with MCCI 
and ,BHP. Hepatocytes were treated with different concentrations of MCCI 
and 500|iM /BHP for 3hr. Cell damage was determined by MTT assay. Each 
value represents mean 土 standard error from 3 experiments, each performed 
in triplicate. Statistical significance was taken as *p<0.01 when compared 
with tBH? only. 
‘ 113 
cell viability to drop to 18% of the control but such damage could be 
partially prevented by treating cells with MCCI simultaneously (Figure 3.2). 
MCCI (100 |ig/ml) reinstated cell viability from 18% to over 80%. In another 
set of experiments, hepatocytes were pre-treated with MCCI for 24hr prior to 
/BHP challenge. The MCCI was removed from the medium before rBHP 
treatment. The MCCI pre-treatment significantly suppressed the cytotoxicity 
of rBHP in a dose-dependent manner (Figure 3.3). Pre- treating hepatocytes 
for 24hr with MCCI (100 |ig/ml) showed similar potency with treating 
hepatocytes with MCCI (100 |ig/ml) simultaneously with /BHR In both cases, 
80-90 % cell viability was observed. 
The results of the time course study on the protective effect of MCCI on 
- ^BHP cytotoxicity are illustrated in Figure 3.4. Significant protective effect 
was observed when hepatocytes has been pre-treated with 100 |ig/ml MCCI 
for 6 hr, over 50% cell viability was observed. The protective effect 
increased with prolonged pre-treatment time with 80 % cell viability for the 
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Figure 3.3 Effect of pre-treatment of hepatocytes with different 
concentrations of MCCI against ^BHP induced cell damage. Hepatocytes 
were pre-treated with MCCI ranging from 3.125 i^ g/ml to 100 ng/ml for 24hr 
prior to tBHP challenge. The MCCI containing media were aspirated before 
adding medium containing 500|iM of rBHP to cells. Cell damage was 
determined by measuring cell viability by MTT assay. Each value represents 
mean 土 standard error from 3 experiments, each performed in triplicate. 
Statistical significance was taken as *p<0.05 and **p<0.01when compared 





100 ‘ r t i 
* * * 
^ SO 、绍 I— —1 
w * * 
p * * 
1 60 T J L , f l ^ 
3 4 � : r 讓 _ 幽 _ • 
. 0 - 1 X ^ ？ I 1 i 
0 1 I M � U C L M _ , fe 
Ctl tBHP 1 6 12 24 48 
only 
Incubation time (hr) 
Figure 3.4 Time course study on the protective effect of MCCI against 
^BHP induced cell damage. Hepatocytes were pre-treated with 100 |ig/ml 
MCCI for various periods of time prior to /BHP treatment. The MCCI 
containing media were aspirated before the addition of 500 |iM /BHP to cells. 
After treatment with ^BHP for 3 hr, cell damage was determined by MTT 
assay. Each value represents mean 土 standard error from 3 experiments, each 
performed in triplicate. Statistical significance was taken as *p<0.05 and 
**p<o 01 when compared with rBHP only. 
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3.4.3 Effects of tBU? and MCCI on hepatocyte GSH and GSSG 
content 
The effect of treating hepatocytes with 出HP and MCCI on intracellular GSH 
content is shown in Figure 3.5. Treating hepatocytes with 500 \iM /BHP for 
3hr led to GSH depletion with a reduction of over 80%. Treating hepatocytes 
with increasing concentrations of MCCI prevented' the rBHP-induced GSH 
depletion in a dose-dependent manner. MCCI (100 |ig/ml) restored GSH 
content to the level of the control group. The effect of MCCI pre-treatment 
on GSH showed a time-dependent pattern (Figure 3.6). Significant increase 
was observed with more than 6 hr pre-incubation in the presence of MCCI. 
On the other hand, there was a consistent decrease in GSSG level in the 
medium. The addition of /BHP (500 |ig/ml) alone led to a 2.45 fold increase 
in GSSG level in the medium which could be decreased in a dose-dependent 
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Figure 3.5 Effect of MCCI on ffiHP-induced GSH depletion in rat 
hepatocytes. Cells were pre-treated with MCCI for 24 hr followed by rBHP 
treatment. Afterwards, the cells were trypsinized and lysed and GSH content 
was determined by spectrophotometeric method with DTNB. Each value 
represents mean 士 standard error from 3 experiments, each performed in 
triplicate. Statistical significance was taken as *p<0.01 when compared with 
腿 P only. 
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Figure 3.6. Time course study of the effect of MCCI against 
/BHP-induced depletion of intracellular GSH level. Hepatocytes were 
pre-treated with 100 |ig/ml MCCI for different time periods, followed by 
/BHP treatment. Cells were trypsinized and lysed for analysis of intracellular 
GSH content. Each value represents mean 土 standard error from 3 
experiments, each performed in triplicate. Statistical significance was taken 
as *p<0.05 and **p<0.01when compared with /BHP only. 
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Figure 3.7 Effect of MCCI on /BHP-induced GSSG formation. 
Hepatocytes were pre-treated with different concentrations of MCCI for 24 
hr followed by /BHP treatment. GSSG released into culture medium was 
converted to GSH by GR. Amount of GSH was measured by adding DTNB 
to the mixture and the amount of GSSG was determined by OD412nm of the 
resulted solution. Each value represents mean 土 standard error from 3 
experiments, each performed in triplicate. Statistical significance was taken 
as *p<0.01 when compared with ^BHP only. 
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3.4.4 Effect of MCCI on lipid peroxidation of hepatocytes 
The addition of /BHP (500 fig/ml) stimulated lipid peroxidation as indicated 
by a 2.8-fold increase in MDA level. Pre-treatment of MCCI to hepatocytes 
led to a dose-dependent decrease in MDA formation with 53% reduction in 
MDA formation compared with that caused by /BHP alone (Figure 3.8). In 
addition, a time-dependent manner could also be observed, with 20 % 
inhibition of MDA formation with Ihr pre-incubation time and up to 50% 
inhibition with 24 hr incubation compared with that caused by 腿 P only 
(Figure 3.9). 
3.4.5 Effect of MCCI on antioxidant enzymes activities 
The effect of MCCI on the four antioxidant enzymes is shown in Figure 3.10. 
There was about 60 % and 20 % increase in the activity of GST and SOD 
‘ respectively after incubation with MCCI (100 |ig/ml) for 24 hr at 37。(：. Such 
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Figure 3.8. Effect of MCCI on /BHP-induced lipid peroxidation. Cells 
were pre-treated with different concentrations of MCCI for 24 hr and then 
treated with /BHR Lipid peroxidation was quantified by measuring amount 
of MDA formed and released into the culture medium. Medium was added to 
TBA reagent and heated at 100°C for 15min. OD532nm of the resulting 
solution was determined. Each value represents mean 土 standard error from 
3 experiments, each performed in triplicate. Statistical significance was taken 
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Figure 3.9 Time course study of the effect of MCCI on rBHP-induced 
lipid peroxidation. Rat hepatocytes were pre-treated with 100 |ig/ml of 
MCCI for various time periods prior to tBH? challenge. MDA formation was 
determined by TBA reagent at OD532nm. Each value represents mean 土 
standard error from 3 experiments, each performed in triplicate. Statistical 
significance was taken as *p<0.01 when compared with tBH? only. 
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Figure 3.10 Effect of MCCI on the activity of different anti-oxidant 
enzymes. Hepatocytes were treated with various concentrations of MCCI for 
24 hr. The cell lysates was obtained for the determination of 
glutathione-S-transferase (GST) ( • ), superoxide dismutase (SOD) ( • ) , 
glutathione reductase (GR) ( • ) and Catalase ( x ) activities. Each value 
represents mean 土 standard error from 3 experiments, each performed in 
triplicate. 
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3.4.6 Comparison with typical antioxidants 
• 
The effect of MCCI on 出HP-induced cytotoxicity is compared with those of 
vitamin E and vitamin C (Figure 3.11). All of these drugs, at the 
concentrations used in this experiment, showed no toxicity on hepatocytes 
(data not shown). Pre-treatment with MCCI (100 ^ig/ml), followed by 
tBH? treatment, resulted in a cell viability of 87%. The effect of MCCI was 
generally intermediate between those of vitamin E and vitamin C. A cell 
viability of 95 % resulted after treatment with vitamin E (100 |ig/ml) 
administration while only 68 % cell viability was observed for vitamin C at 
the same dosage. 
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Figure 3.11 Effect of MCCI and vitamin C and E on ffiHP-induced 
cytotoxicity. Hepatocytes were pre-treated with different concentrations of 
MCCI ( • ) , vitamin E (•)，vitamin C ( • ) for 24 hr and then treated with 
SOOfiM 出HP for 3hr. Cell damage was assessed by determining cell viability 
with the MTT assay. Each value represents mean 土 standard error from 3 
experiments, each performed in triplicate. 
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3.5 Discussion 
The anti-oxidant properties of MCCI were tested by the hepatocyte model 
using the organic peroxide /BHP to produce oxidative stress. Incubation of 
rat hepatocytes with 500 \iM rBHP for 3hr led to significant oxidative 
damage, as shown by the loss of cell viability, GSH depletion and MDA 
formation. Such results agreed with previous studies using the same system 
(Dubuisson et al” 2000; Kmonickova et a!., 2001). tBH? is metabolized 
intracellularly by microsomal CYP450 reductase to form free radical 
intermediates inside the cells. Therefore, the proposed antioxidant should be 
permeable to cellular membrane and concentrates at the site of free radical 
generation in order to protect the cells, or it should trigger intracellular 
signaling pathway. A pre-treatment scheme was used in the present study in 
which unabsorbed MCCI was removed. Thus, any antioxidant activity 
observed should occur intracellularly, and as a consequence of reacting with 
‘ rBHP directly in the culture medium. 
The lack of cytotoxicity should be a prerequisite for pharmacological studies 
on protease inhibitors. Administration of some protease inhibitors may cause 
cell death even though they may exert some beneficial functions. For 
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example, a cysteine protease inhibitor ABT-987 possessed anti-hepatoma 
effect, but it induced hypertrophy or cell death on normal hepatocytes (Moin 
et al., 2000). In the present experiment, it was shown that MCCI had very 
low toxicity on hepatocytes. The introduction of another serine protease 
inhibitor, secretory leukocyte protease inhibitor (SLPI) to cerebellar granule 
neurons has been reported to result in only less than 10% toxicity up to a 
concentration of 1 mg/ml (Monti et al, 1998). • 
Pre-treatment experiments were done in which all MCCI was supposed to be 
washed away before addition of 沿HP. Cell viability was generally higher 
after the pre-treatment experiment when compared with results from the 
experiment in which MCCI and 出HP were added simultaneously. Obviously, 
the cell-reviving effect of MCCI is not attributed to a direct interaction 
between MCCI and tBW. Instead, it may be explained by activation of a 
downstream signaling pathway resulting from the absorption of MCCI into 




sulfonate) is a synthetic protease inhibitor of 417 daltons that inhibits trypsin, 
kallikrein, plasmin (even when bound to alpha2-macroglobulin). Intravenous 
administration of the drug to patients is useful in preventing I/R injury of 
human liver through the internalization of the drug into hepatocytes (Kim et 
al., 2002). While drug absorption of drug into cells is generally accepted for 
drugs with molecular weight under one kilodalton, there are also reports for 
absorption of drugs of several kilodaltons. There are some high affinity 
receptors on the hepatocyte membrane for binding or internalization of 
macroglobulin-proteinase complex (Petersen et al., 1988). It is also possible 
that MCCI, a serine protease inhibitor, also binds to the receptor complex 
with protease or macroglobulin-protease and triggers off the downstream 
signaling pathway. The present result implies that MCCI could be useful for 
inhibiting acute oxidative stress induced by exogenous agents and it is 
capable of enhancing the antioxidant capacity of our bodies. 
The antioxidant activity of MCCI was further investigated with several 
oxidative stress-related parameters. The metabolism of tBU? by GPx results 
in a rapid consumption of intracellular GSH. Besides this enzymatic 
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detoxification pathway, free radicals generated via ^BHP metabolism by 
CYP450 system also lead to GSH oxidation. The rBHP-induced decrease of 
intracellular GSH was found to be recovered by MCCI (Figure 3.5). On the 
other hand, MCCI suppressed the level of GSSG in the pre-treatment 
experiment (Figure 3.7). The elevated level of GSH is commonly attributed 
by the increase in activity of GR which is the main enzyme for the recycling 
of GSH from GSSG. However, no significant increase in GR activity was 
observed in this study (Figure 3.10). The hepatic GSH level is also controlled 
by the y- glutamyl cycle in which the biosynthesis and breakdown of GSH 
ifivolve glutathione synthetase and y-glutamyl transpeptidase respectively. 
Thus, changes in the activities of these two enzymes could be another 
possibility for the increase in GSH level in the MCCI pre-treated 
hepatocytes. 
Antioxidant enzymes are the first line of defense against oxidative stress in 
cells. It was found that MCCI could increase the activities of intracellular 
antioxidant enzymes： There was 60% and 20 % increase in the enzymatic 
activity of GST and SOD respectively. However, no increase in GR was 
observed. To date, there have been no reports on the increase in the activities 
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of antioxidant enzymes due to protease inhibitors. On the other hand, an 
increase in interleukin-6 has been shown to be effective in hepatocyte 
protection and this may be related to the activation of some intracellular 
antioxidant enzymes (Sato et al, 1995). The SOD activity could be induced 
by some inflammatory cytokines, for example, TNF-a could significantly 
increase MnSOD activity in intestinal cells (Kuratko and Constante, 1998). It 
was found that MCCI could increase intracellular TNF-a production in 
macrophages (data not shown), however, it remains unknown whether there 
is any increase in TNF-production in hepatocytes which might increase the 
SOD activity. To understand the increase in GST activity, cytochrome P450 
inhibitor could be used as the increase in GST activity are accompanied by 
the activation of the cytochrome P450 system (Maurat et al., 2001). 
Lipid peroxidation plays an important role in mediating tBH? toxicity. The 
• 仗"-butylperoxyl and tert-hutoxy\ radicals can initiate the lipid peroxidation 
chain reaction. MCCI showed an inhibition on lipid peroxidation (Figure 3.9). 
The proposed antioxidant could be located near the site of free radical 
generation i.e. microsome, scavenge free radical immediately after being 
generated or it may interact with the lipid peroxides formed if any 
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butylperoxyl radicals escape from the first line of defense at the microsomal 
site. As MCCI is a small protein of 7.5 kDa, it is unlikely for it to exert any 
scavenging ability. Instead, MCCI may disturb the signaling pathway for the 
peroxidation reaction by interacting with the intermediates. Iron and some 
iron chelators (e.g. ADP) are believed to be involved in both the initiation 
and re-initiation phase of lipid peroxidation (Minotti and Aust 1987). Many 
inhibitors of lipid peroxidation, e.g., a hydroxylamine-including compound 
called OXANO, was found to oxidize the ferrous-ADP complex required for 
the initiation of peroxidation (Nilsson et al., 1990). In addition to interacting 
with iron or iron chelators, MCCI may also interact with enzymes in the 
cytochrome P450 system, e.g. NADPH-cytochrome P450 reductase which is 
mainly responsible for the initiation of lipid peroxidation. The potency of 
MCCI was compared with two typical antioxidants, namely vitamin C and 
vitamin E. Among the three, vitamin E was the most potent lipid 
peroxidation chain breakers. This property is due to the high solubility of 
vitamin E in membrane lipid bilayer. 
Both vitamin C and vitamin E are essential in protecting cell against 
oxidative stress induced by tBH? (Glascott et al., 1992; Sun et aL, 2000). 
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The lipid-soluble vitamin E protects hepatocyte from /BHP induced lipid 
peroxidation, while the aqueous-soluble vitamin C mainly scavenges free 
radicals in the cytosol. Vitamin C exerts protective effect against rBHP 
toxicity through synergetic actions on vitamin E (Sun et al.，2000). MCCI is 
not a typical aromatic compound which is important for direct scavenging 
ability for free radicals generated in microsome so as to prevent initiation of 
lipid peroxidation chain. Thus, MCCI may interact with the receptors on cell 
membrane or the intermediates, e.g, ADP complex in the signaling pathway 
and eventually breaking peroxidation chain effectively; or MCCI may 
,perform synergetic action upon the chain breaking activity of vitamin E on 
the membrane of hepatocytes, just like the case in vitamin C. It is reasonable 
that the inhibition of MCCI on lipid peroxidation was weaker than that of 
vitamin E as vitamin E can block the process at the very beginning step while 
MCCI could only interrupt at the intermediate steps. 
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Chapter 4 Cytotoxicity of MCCI on tumor cell 
lines 
4.1 Introduction 
4.1.1 Relationship between protease inhibitors and cancer 
Cancer is one of the leading causes of death around the world. A great 
variation in cancer incidence with different diet has been observed 
(Fitzgeriald et al, 2002). Epidemiological data suggest that environmental, 
especially nutritional, factors play a major role in the etiology of cancer at 
different sites (Schattner, 2003). There are now many different 
epidemiological studies which suggest that compounds in vegetables, 
particularly legumes (Jang et al, 2003), may play a beneficial role in 
lowering the incidence of cancer. Rice, maize and beans, all of which known 
‘ to contain high level of protease inhibitors, in the diet are associated with a 
* • 
‘ reduced incidence of colon, breast and prostate cancers (Jang et al, 2003). 
The intake of breads and cereals, food sources which are also known to 
I 
contain high level of protease inhibitors, has also been associated with a 
lower incidence of oral or pharyngeal cancers (Chainani-Wu, 2002). The 
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anti-carinogenic activity of protease inhibitor has become a hot topic in 
cancer research. There are currently some clinically use drugs in cancer 
treatment. They are grouped according to their action mechanisms. However, 
different kinds of side effects are accompanied. 
Protease inhibitors are unique in that they interfere with cancer development 
in a variety of ways, including suppression of oxygen radicals, oncogenes, 
and metastases as well as triggering off apoptosis. The Bowman-Birk 
inhibitor has been found to be effective in reducing the oncogene c-myc level 
in the radiation-transformed fibroblast cells (Dittmann et al, 1995). The 
prevention and suppression of cancer would be easily achieved by looking at 
the cause of cancer. It has been suggested that cancers caused by 
carcinogen-induced malignant transformations, a high frequency event 
occurring in many cells, are induced by a change in gene expression. Such 
ongoing cellular process induced by carcinogens could be effectively stopped 
by serine protease inhibitors (Kennedy, 1985). Likewise, the transformation 
of murine fibroblasts by carcinogens was found to be suppressed by 
chymotrypsin-specific protease inhibitor (Kennedy, 1985). 
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Protease inhibitor preparations (PIP) with antichymotryptic activities isolated 
from field bean legume, like doxorubicin and cyclophosphamide, could 
effectively suppress the growth of Yoshida sarcoma ascites tumor cells 
transplanted in adult rats and prevent their death (Femandes and Banerj, 
1997). Meanwhile, the cytotoxic effect of serine protease inhibitors (TPCK) 
has also been demonstrated in leukemia cells HL 60 by triggering apoptosis 
(Lu and Mellgren, 1996). 
The relationship between protease inhibitors and mammary tumor seems to 
be closer than other tumor cell lines. In mice, long-term feeding of protease 
inhibitor from soybean origin suppressed virus-induced mammary 
carcinogensis (Femandes and Banerji, 1997). On the other hand, TPCK, a 
potent serine protease inhibitor was found to exert a growth suppression 
effect of 2.5 fold in MCF-7 which was accompanied by a 4-fold increase in 
the level of the heat shock protein HSP27. It was proposed that TPCK was 
involved in the inhibition of the proteases which cleave the heat shock 
protein involved in determining cell growth (Horman et al” 2000). 
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Researches on the anti-tumor activity of serine protease inhibitors have been 
emphasized in the last two decades. The value of serine protease inhibitors 
on anti-carcinogenic properties may be confirmed by purifying and 
characterizing more serine protease inhibitors. 
4.1.2 Cell cycle and apoptosis 
The growth and division of cells are well regulated by the control of the "cell 
cycle clock". The cell cycle clock consists of four well characterized stages 
known as Gl, S, G2 and M phase. In G1 phase, a cell increases in size and 
prepares to duplicate its DNA. During the S phase, the cellular DNA is 
duplicated and a complete copy of the chromosome complement is made. 
After that cell enters the G2 phase and prepares itself for division. In the M 
phase, each cell divides by mitosis. There is another phase, GO, which is the 
, resting stage of a cell. 
^ The cell cycle machinery is controlled by a variety of genes and gene 
products. Some of these products are cyclins and cyclin-dependent kinase 
(cdks) which become activated only in the presence of cyclins. Within the 
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cell cycle, there is a decision point called restriction point (R point), located 
at the end of Gl, which decides whether a cell should enter the rest of the cell 
cycle for division or not. The retinoblastoma protein (pRB) is the molecular 
control of R point. There is also a D-type cyclin (cyclin D) which can be 
induced to express by the growth signals. Cyclin D acts as a mediator in 
combination with cdks. When the cell receives mitotic signals, cyclin D 
becomes activated. It acts in association with cdk4 or cdk6 and initiates the 
phosphorylation of pRB. The partially phosphorylated pRB subsequently 
undergoes further phosphorylation by a number of cyclin/cdks and permits 
the cell to enter and progress in the cell cycle (Watanabe et al, 1999). 
Apoptosis is a major physiological mechanism of cell death. Its regulation is 
highly conserved with similar or the same gene controlling processes present 
in a wide variety of species. It is a general biological phenomenon necessary 
for development and homeostasis. Apoptosis is characterized by a series of 
typical morphological and biochemical features, such as shrinkage of cell, 
( chromatin aggregation, nuclear and cytoplasmic condensation, 
internucleosomal fragmentation of genomic DNA, fragmentation into 
membrane-bound apoptotic bodies and rapid phagocytosis by neighbouring 
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cells (Catchpole and Stewart, 1995). 
A number of stimuli can induce a cell to commit apoptosis. These stimuli 
include genotoxic damage (e.g. radiation, chemotherapy) and deprivation of 
growth factors (e.g. EPO). During apoptosis, there is a group of enzymes 
called caspases, which are cysteine protease, mediating the terminal steps of 
apoptosis. Caspases are classified as either initiator (caspases 2, 8，9，10) or 
effectors (caspases 3，6，7). The initiators activate the effectors which result 
in cleavage of cytoskeletal proteins, disruption of nuclear membrane and 
cell-cell contact, and activation of DNA nuclease to allow DNA 
fragmentation. These irreversible proteolytic events are responsible for the 
morphological characteristics of apoptosis. There is a family of caspase 
inhibitors, lAPs (inhibitor of apoptosis), which are overexpressed in many 
malignant cells. These inhibitors can selectively inhibit the effector caspases 
and therefore, blocks the apoptotic process (Eymin et al, 1999). 
> 
Very few investigations have been done on the induction of apoptosis by 
protease inhibitors. Lu and Mellgren (1996) have reported that 
N-tosyl-L-phenylalanine-chloromethylketone (a serine protease inhibitor) 
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could induce apoptosis in HL 60. Zhu et al (1996) reported that some 
aspartate inhibitors could activate heat-induced apoptosis. On the contrary, 
much emphasis was put on the role of the inhibitor in the prevention of 
apoptosis (Yang et al, 1997; Mederna et al, 2001). 
4.2 Rationale of the present study 
Cancer chemotherapy using conventional chemotherapeutics is generally not 
very effective. Its side-effects, for example, suppression of host immunity, 
are harmful due to an accelerating induction of metastasis. Moreover, the 
adverse immune response triggered off by external administration of the drug 
is another consideration. The best method, perhaps, is to potentiate host 
resistance against cancer so as to suppress the proliferation of cancer cells. 
Protease inhibitors may help to get rid of the initiation of unwanted immune 
responses. Some protease inhibitors have been reported to modulate the 
downstream pathway for the growth of cells by disturbing the expression of 
oncogene or inducing apoptosis (Lu and Mellgren, 1996). Thus, it deserves 
to be studied as a potential agent for cancer therapy. 
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4.3 Materials and methods 
4.3.1 Materials 
L-Glutamine was obtained from GibcoBril. Fetal calf serum (FCS), 
RPMI 1640 medium, Penicillin, streptomycin sulfate, toxicants, and other 
chemicals e.g. RNase A, proteinase K and propidium iodide for flow 
cytometry were purchased from Sigma. HepG2, MCF-7 and HL60 were 
purchased from American Type Culture Collection. 
4.3.2 Cell culture 
Tumor cells were grown in RPMI medium with 10% heat inactivated fetal 
calf serum, 100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM 
L-glutamine under standard tissue culture conditions. They were plated in 
‘ 96-well plates at a density of 4 x lO'^  cells/well. For further experiments, cells 
were first washed twice with serum-free RPMI medium. 
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4.3.3 MTT assay 
Tumor cells were seeded onto 24-well plate for cytotoxicity experiment. A 
MTT stock of 5mg/ml was prepared in PBS and filtered through a 0.2|im 
filter to remove undissolved MTT powder. The MTT stock solution was 
diluted to 0.5 mg/ml with serum free RPMI 1640 medium. After different 
treatments, the tumor cells were washed with PBS twice and 400}il of diluted 
MTT solution was added to each well. The formazan crystals formed in 
active metabolic cells were extracted with 400^il 10% SDS in lOmM HCl 
after 2hr of incubation at 37°C. For blank, SDS solution was used. The 
absorbance at 540 nm was measured. Cell viability was calculated as 
follow: 
% viability = [(OD540 treated group - blank)/(OD540 control - blank)] x 100% 
4.3.4 Cell cycle analysis 
To determine cell cycle distribution, 5 x 10^  cells were seeded in 3 ml 
^ ^ experimental medium in 6-well plate and incubated at 37 5 % CO2 
incubator for 24 hr. The medium was removed and drugs at various 
concentrations were added to each well in 3 ml experimental medium, both 
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floating and trypsinized adherent cells were collected, washed with 
phosphate-buffered saline twice, and fixed with 70% ethanol for 30 min. 
After fixation, cells were washed with PBS and stained with propidium 
iodide solution (2 mg/ml), RNase A (1 mg/ml) and 400 jil PBS for 30 min 
for 37 OC. Stained cells were analyzed using FACSort flow cytometer 
(Becton Dickinson). With 'CellQuest' program, the cell population was 
targeted by forward light scatter (FSC) and side scatter (SSC). The 
fluorescence signal of propidium iodide was collected at channels of FL-2. 
The percentages of DNA content at different phases of cell cycle were 
,analyzed with Modfit software. 
4.3.5 DNA fragmentation 
Tumor cells (4 x 10 )^ were plated on 6-well plates and incubated with 
MCCIs for varying times. Media containing the detached cells were 
centrifuged at 1600 g for 5 min at 4°C. Pellets were dissolved in 20 \i\ of 
sample buffer [50 mM Tris-HCl, 0.5% SDS, 10 mM EDTA, pH 8.0] and 
incubated with 100 |ig/ml RNase A at 50°C for 1 hr Proteinase K (1 mg/ml) 
was added to each sample and incubated for 1 hr at 50�C. The reaction was 
stopped by increasing the temperature to 70°C for 10 min. Samples were 
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loaded to 1 % agarose gel. After electrophoresis, the gel was stained with 
ethidium bromide. 
4.4 Results 
4.4.1 Cytotoxicity of MCCI 
The effect of MCCI on the growth of different tumor cell lines was 
investigated by MTT assay. A dose-dependency was observed. There were 
about 15 %, 25% and 50% growth inhibition on HL 60, MCF-7 and HepG2 
respectively with 200ug/ml of MCCI administration (Figure 4.1). In the 
time-course experiment, it appears that for MCF-7 and HepG2, the growth 
inhibitions at 48 hr and 72 hr were roughly the same (Figure 4.2). 
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Figure 4.1 Effect of MCCI on different cancer cell lines. HepG-2 (liver 
cancer cells) ( • ) , MCF-7 ( breast cancer cells ) ( • ) and HL 60 (leukemia 
cells) (•) were cultured at a cell density of 2 x 10^  cells/well in a total volume 
of 0.2 ml with different concentrations of MCCI in a 96-well flat bottom 
microtiter plate. After 48 hr incubation, the growth of the cells was tested by 
MTT assay. Each value represents mean 土 standard error from 3 experiments, 
each performed in triplicate. 
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Figure 4.2 Time courses of the effect of MCCI on different tumor cell 
lines. HL60 (grey), MCF-7 (black) and HepG2 (white). Cells were cultured 
at a cell density of 2 x 10^  cells/well in a total volume of 0.2 ml with 200 
|ig/ml MCCI in a 96-well plate. After different incubation time periods, the 
growth of the cells was tested by MTT assay. Each value represents mean 土 
standard error from 3 experiments, each performed in triplicate. 
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4.4.2 Cell cycle and apoptosis analysis 
In the experiment on cell cycle progression, cells were incubated with 100 
|Lig/ml and 200 |ig/ml MCCI for the time period of maximum growth 
inhibition. Two different concentrations of MCCI were administrated to see 
if there was a dose-dependent response. As shown in Figures 4.3.^.5, 
GO/Gl phase arrests were observed for HepG2 and MCF-7 by 200 i^g/ml of 
MCCI which corresponds to 50% and 25% growth inhibition in HepG2 and 
MCF-7 respectively. For HepG2, GO/Gl phase arrest was indicated by the 
percentage of the cell in the phase, from 47.28% (control) to 56.69 and 
66.51% with 100 |ag/ml and 200 i^ g/rnl MCCI respectively. The percentage 
of cells arrest in the GO/Gl phase with the same dose of MCCI in MCF-7 is 
- less than that in HepG2, from 46.28% (control) to 51.68% and 59.78 % with 
100 pig/ml and 200 |ag/ml MCCI respectively. On the other hand, the 
percentage of the cells in the GO/Gl phase in the treated HL 60 did not show 
any significant increase when compared with the control. Figure 4.6 shows 
the genomic DNA pattern of HepG2, MCF-7 and HL 60 after treatment with 
� 
MCCI. No DNA fragmentation was observed in all cases. 
‘ 147 
, MCCI 100 昭/ml | g o / G i | g 2 / M | s | s u ^ 
, Control % 47.28 11.82 40.90 0.10 
Treated % 56.69 10.16 33.15 0.18 
�• 
I Control 
i . j L^^^^^^t^^’  
0 ,023 
FU-H 
MCCI 200 | i g / m l |gO/G1 G2/M S _ SubGl 
Control % 47.28 11.82 40.90 0.10 
Treated % 66.51 8.38 25.11 0.14 
1 
Control 
I I  
Figure 4.3 Effect of MCCI on cell cycle arrest in HepG2 cell line. Cells 
, were incubated with 100 and 200 |ig/ml MCCI for 72 hr, and cell cycle 
analysis was performed by flow cytometry. The population of cells in each 
phase were determined by FACSort flow cytometer and analyzed by Modfit 
LT. Y-axis represent events while X-axis represent the FL2A signal. 
Percentage of cell at various phases is shown in the table. Data is a 
representative of three separate experiments. 
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Figure 4.4 Effect of MCCI on cell cycle arrest in MCF-7 cell line. Cells 
were incubated with 100 and 200 |ig/ml for 72 hr, and cell cycle analysis was 
performed by flow cytometry. The population of cells in each phase were 
determined by FACSort flow cytometer and analyzed by Modfit LT. Y-axis 
represent events while X-axis represent the FL2A signal. Percentage of cell at 
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Figure 4.5 Effect of MCCI on cell cycle arrest in HL 60 cell line. Cells 
were incubated with 100 and 200^g/ml for 24 hr，and cell cycle analysis was 
performed by flow cytometry. The population of cells in each phase were 
determined by FACSoit flow cytometer and analyzed by Modfit LT. Y-axis 
‘ represent events while X-axis represent the FL2 A signal. Percentage of cell at 
various phases is shown in the table. Data is a representative of three separate 
experiments. 
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Figure 4.6 Effect of MCCI on genomic DNA fragmentation in HepG2， 
MCF-7 and HL 60 cell lines. Cells were incubated with MCCI for different 
time periods and nuclear DNA was isolated, electrophoresed on 1% agarose 
gel and stained with ethidium bromide. A ready-load 1-kB DNA ladder was 
used as a standard (lanes 1 and 6). Lanes 3, 4 and 5 represent DNA from HL 
60 incubated with 0，100 and 200 [Lg/m\ MCCI respectively for 48 hr. Lanes 7， 
8 represent DNA from MCF-7 incubated with 100 |ig/ml and 200 |ig/ml 
MCCI respectively for 72 hr. Lanes 9，10 represent DNA from HepG2 





HL 60，MCF-7 and HepG2 cells have long been used for screening 
anti-tumor compounds (Lu and Mellgren, 1996; Shutt et al, 2003). In the 
present study, MCCI showed very little cytotoxicity towards HL60 cells at 
concentrations up to 200 fig/ml. In the literature, there are no reports about 
inhibition on the growth of leukemia cell lines by protease inhibitors. On the 
contrary, a human secretory leukocyte protease inhibitor (hSLPI), a 12 kDa 
nonglycosylated serine protease inhibitor originally isolated from human 
parotid secretions, was found to be strongly expressed in P388 leukemia and 
L5178Y lymphoma (Morita et al., 1999). It has been suggested as a kind of 
self-protection against excessive proteolysis by secreted proteases like matrix 
metalloproteinases which play a critical role in the degradation of 
extracellular matrix in invasive tumor cells. 
On the other hand, MCCI showed moderate inhibition on the breast cancer 
cell line MCF-7: about 25 % inhibition at 200 ^ig/ml MCCI. In the epithelial 
—x 
’丨 
cells of the mammary gland, a serine protease inhibitor (maspin) is expressed 
and it is down-regulated in breast cancer cells with high malignancy (Zhang 
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et al, 1999). It has been demonstrated that serine protease inhibitors regulate 
the expression of estrogen receptors in different breast cancer cell lines, 
which determine metastasis. 
In the case of the liver cancer cell line HepG2, there was about 50% growth 
inhibition with 200 |Lig/ml MCCI. It showed the greatest inhibition when 
compared with HL 60 and MCF-7. There was a report on the inhibition of 
protein metabolism in HepG2 cells by a serine protease inhibitor, tosyllysine 
chloromethyl ketone (TLCK) (Mcllhinney and Hogan, 1974). Protein 
metabolism was supposed to be involved in the growth control of HepG2. 
However, there are no publications about the direct growth inhibition effect 
of serine protease inhibitors so far. In this experiment, MCCI, a serine 
protease inhibitor purified from the seed of Momordica cochinchinensis, was 
found to be more potent on the growth inhibition of liver cancer cell line. 
‘ The growth inhibition effect of MCCI on HepG2 may probably be due to the 
GO/Gl phase arrest as there was about 40 % increase of cells in the GO/Gl 
� phase for HepG2 cells treated with 200 |ig/ml MCCI. Recently, Caputo et al. 
(2003) found that 1,25-dihydroxyvitamin D3 induced cell cycle arrest in 
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HepG2 and it was accompanied by the binding of 1,25-dihydroxyvitamin D3 
to specific receptors on the cell. Thus, it awaits to be elucidated whether 
there are any receptors for the binding of protease inhibitors in HepG2, just 
like the proteases complex receptors found in the neutrophils for the binding 
of a-macroglobulin. If there is any, further investigation on whether MCCI 
could bind to the soluble or membrane-bound receptors in HepG2 should be 
followed. 
The GO/Gl phase arrest was also observed in MCF-7, however, the increase 
percentage was lower, about 26.4% increase with 200 |ig/ml MCCI. This is 
consistent with the results in the growth inhibition study as the growth 
inhibition effect of MCCI on MCF-7 (25%) was also about half of that for 
HepG2 (50%) (Figure 4.1). A serine protease inhibitor has been shown to 
suppress the growth of MCF-7 with an increase in the level of heat shock 
protein HSP27. However, the effect of protease inhibitor on cell cycle 
progression has not been investigated, although it is well known that heat 
shock proteins are involved in the cycle retardation (Zhao et al.’ 2002; He 
and Fox, 1997; Fuse et al., 1996). 
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MCCI did not affect the cell cycle progression in HL 60. In fact, the effect of 
serine protease inhibitors in HL 60 (leukemia cells) is relatively complex as 
proposed by Lu and Mellgren (1996). They found that a serine protease 
inhibitor (TPCK) exerts two different actions towards HL 60. In the presence 
of certain apoptosis inducers, the protease inhibitor suppresses apoptosis 
while it stimulates apoptosis in the absence of the inducer. However, in this 
study, there was no evidence for apoptosis even in the absence of apoptosis 
inducer. There was no report for induction of cell cycle arrest by protease 
inhibitors in HL 60. Heat shock protein might also be involved in the cell 
cycle progression in HL 60. The induction of HSP by external reagents has 
only been reported in the case of administration of retinoic acids which 
resulted in G1 phase arrest (Dierov et al., 1999). Further experiments to 
investigate the relationship between protease inhibitors and heat shock 
protein in HL 60 may yield important information about the cell cycle 
progression. No apoptosis was observed in the MCCI-treated HepG2, MCF-7 
and HL 60, as shown by the results of DNA fragmentation: no DNA ladder 
was observed in all cases (Figure 4.6). There has been no report on the 
A 
induction of apoptosis in HepG2 by protease inhibitors although it is known 
that there are some cell-specific protease inhibitors which mainly targets on 
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leukemia cell (Lu and Mellgren, 1996). The negative results for the effect of 
serine protease inhibitors on the induction of apoptosis is not unexpected as 
apoptosis is mainly regulated by cysteines protease inhibitors which interact 
with the caspases in the apoptotic pathway (Eitel et al, 1999). 
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Conclusion and future perspectives 
Serine protease inhibitors are widely distributed in plant kingdom and a 
lot of them have been purified and characterized from different species. 
Trypsin inhibitors, the most popular member within the class, have been 
well-investigated so far. On the other hand, information about 
chymotrypsin inhibitors is relatively less and although its physiological 
functions become more popular in recent years. 
‘Momordica cochinchinensis chymotrypsin inhibitor (MCCI) was the first 
chymotrypsin-specific potato type I inhibitor isolated from Cucurbitaceous 
plants. It was purified from the seeds of Momordica cochinchinensis by 
using a combination of affinity and CI8 reversed-phase liquid 
chromatography (RP-HPLC). Based on the molecular weight and 
‘ sequence analysis, MCCI was believed to belong to the family of potato 
type I inhibitor. The specificities of MCCI towards different proteases was 
: that its inhibitory activity against chymotrysin and subtilisin was at least 
50-fold higher than that against elastase and trypsin. 
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The effect of serine protease inhibitors on different immune cells had been 
emphasized, especially for neutrophils and splenocytes. The investigation of 
MCCI was extended to bone marrow, splenic lymphocytes and macrophage 
in this study. MCCI was believed to have immuno-enhancing and 
anti-inflammations effects as MCCI could greatly stimulate the proliferation 
of different immune cells, for example, splenocytes, splenic lymphocytes, 
bone marrow cells accompanied by an increase in IL 2 production in 
splenocytes and lymphocytes. The stimulatory effect could be compared to 
that of ConA. In order to further characterize its anti-inflammation activity, 
‘the in vitro effect on the production of tumor necrosis factor alpha (TNF-a) 
or some anti-inflammatory cytokine, e.g. interleukin 10 in various cells 
should be followed. 
MCCI was found to be effective in the inhibition of lipid peroxidation as well 
, as the increase of intracellular GSH level which are the main features for 
enhancement of antioxidant capacity of hepatocytes. In addition, MCCI 
) could increase the activity of the antioxidant enzyme, 
glutathione-S-transferase and superoxide dismutase to different extent. MCCI 
could be regarded as a hepato-protective agent. In fact, there were some 
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researches on the treatment of IR of liver by serine protease inhibitors (Kim 
et al., 2002). Again, in vivo experiments should be done to confirm its effect. 
The anti-tumor activity of serine protease inhibitors was a hot topic during 
the last two decades. Though the effect of MCCI on the tumor cell lines 
tested was not very promising, MCCI should be administrated to neural 
tumor cells as there is a close relationship between serine protease inhibitor 
and the growth or the differentiation of neural cells. 
The immunopharmacological property of a serine protease inhibitor (MCCI) 
was explored in this study. With further effort, it is expected that the role of 
the serine protease inhibitor on medicinal therapy could be identified, just 
like the Bowman-Birk inhibitor from soybean which went to the clinical trial 
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